{"id":315907,"date":"2025-07-19T11:47:06","date_gmt":"2025-07-19T11:47:06","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/is-pfe-a-good-stock-to-buy-2\/"},"modified":"2025-07-19T11:47:06","modified_gmt":"2025-07-19T11:47:06","slug":"is-pfe-a-good-stock-to-buy","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/","title":{"rendered":"&#8220;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&#8221;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\"><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":184208,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[28,39,45,44],"class_list":["post-315907","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trading","tag-investment","tag-platform","tag-stock","tag-strategy"],"acf":{"h1":"Pocket Option ti\u1ebft l\u1ed9: PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m hi\u1ec7n nay kh\u00f4ng?","h1_source":{"label":"H1","type":"text","formatted_value":"Pocket Option ti\u1ebft l\u1ed9: PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m hi\u1ec7n nay kh\u00f4ng?"},"description":"PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua trong th\u1ecb tr\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng n\u0103m 2025 kh\u00f4ng? Kh\u00e1m ph\u00e1 l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c 5.4% c\u1ee7a Pfizer, nh\u1eefng \u0111\u1ed5i m\u1edbi trong danh m\u1ee5c s\u1ea3n ph\u1ea9m v\u00e0 c\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 v\u1edbi ph\u00e2n t\u00edch chuy\u00ean gia c\u1ee7a Pocket Option","description_source":{"label":"Description","type":"textarea","formatted_value":"PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua trong th\u1ecb tr\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng n\u0103m 2025 kh\u00f4ng? Kh\u00e1m ph\u00e1 l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c 5.4% c\u1ee7a Pfizer, nh\u1eefng \u0111\u1ed5i m\u1edbi trong danh m\u1ee5c s\u1ea3n ph\u1ea9m v\u00e0 c\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 v\u1edbi ph\u00e2n t\u00edch chuy\u00ean gia c\u1ee7a Pocket Option"},"intro":"\u0110i\u1ec1u h\u01b0\u1edbng b\u1ed1i c\u1ea3nh \u0111\u1ea7u t\u01b0 d\u01b0\u1ee3c ph\u1ea9m \u0111\u00f2i h\u1ecfi s\u1ef1 ch\u00ednh x\u00e1c ph\u00e2n t\u00edch trong th\u1ebf gi\u1edbi h\u1eadu \u0111\u1ea1i d\u1ecbch. Ph\u00e2n t\u00edch d\u1ef1a tr\u00ean d\u1eef li\u1ec7u n\u00e0y xem x\u00e9t ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 c\u1ee7a Pfizer (PFE) th\u00f4ng qua 5 ch\u1ec9 s\u1ed1 ch\u00ednh: l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c (hi\u1ec7n t\u1ea1i 5,4%), t\u1ef7 l\u1ec7 P\/E (12,7), tri\u1ec3n v\u1ecdng \u0111\u01b0\u1eddng \u1ed1ng (43 \u1ee9ng vi\u00ean Giai \u0111o\u1ea1n 3), c\u00e1c v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c nh\u01b0 Seagen, v\u00e0 hi\u1ec7u su\u1ea5t so s\u00e1nh c\u1ee7a ng\u00e0nh - gi\u00fap b\u1ea1n x\u00e1c \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 x\u1ee9ng \u0111\u00e1ng c\u00f3 m\u1ed9t v\u1ecb tr\u00ed trong danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n hay kh\u00f4ng.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0110i\u1ec1u h\u01b0\u1edbng b\u1ed1i c\u1ea3nh \u0111\u1ea7u t\u01b0 d\u01b0\u1ee3c ph\u1ea9m \u0111\u00f2i h\u1ecfi s\u1ef1 ch\u00ednh x\u00e1c ph\u00e2n t\u00edch trong th\u1ebf gi\u1edbi h\u1eadu \u0111\u1ea1i d\u1ecbch. Ph\u00e2n t\u00edch d\u1ef1a tr\u00ean d\u1eef li\u1ec7u n\u00e0y xem x\u00e9t ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 c\u1ee7a Pfizer (PFE) th\u00f4ng qua 5 ch\u1ec9 s\u1ed1 ch\u00ednh: l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c (hi\u1ec7n t\u1ea1i 5,4%), t\u1ef7 l\u1ec7 P\/E (12,7), tri\u1ec3n v\u1ecdng \u0111\u01b0\u1eddng \u1ed1ng (43 \u1ee9ng vi\u00ean Giai \u0111o\u1ea1n 3), c\u00e1c v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c nh\u01b0 Seagen, v\u00e0 hi\u1ec7u su\u1ea5t so s\u00e1nh c\u1ee7a ng\u00e0nh - gi\u00fap b\u1ea1n x\u00e1c \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 x\u1ee9ng \u0111\u00e1ng c\u00f3 m\u1ed9t v\u1ecb tr\u00ed trong danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n hay kh\u00f4ng."},"body_html":"<div class=\"custom-html-container\">\n<h2>S\u1ef1 Thay \u0110\u1ed5i C\u1ee7a C\u1ea3nh Quan \u0110\u1ea7u T\u01b0 D\u01b0\u1ee3c Ph\u1ea9m<\/h2>\nNg\u00e0nh d\u01b0\u1ee3c ph\u1ea9m t\u1eeb l\u00e2u \u0111\u00e3 mang \u0111\u1ebfn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1ed9t s\u1ef1 k\u1ebft h\u1ee3p \u0111\u1ed9c \u0111\u00e1o gi\u1eefa \u0111\u1eb7c \u0111i\u1ec3m ph\u00f2ng th\u1ee7 v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng. Trong b\u1ed1i c\u1ea3nh c\u1ea1nh tranh n\u00e0y, Pfizer Inc. (NYSE: PFE) \u0111\u1ee9ng th\u1ee9 4 trong s\u1ed1 c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m l\u1edbn nh\u1ea5t to\u00e0n c\u1ea7u theo doanh thu, v\u1edbi v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng v\u01b0\u1ee3t qu\u00e1 200 t\u1ef7 USD. C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u01b0\u1eddng h\u1ecfi: li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua trong m\u00f4i tr\u01b0\u1eddng th\u1ecb tr\u01b0\u1eddng hi\u1ec7n nay? C\u00e2u h\u1ecfi n\u00e0y \u0111\u00f2i h\u1ecfi ph\u1ea3i xem x\u00e9t n\u0103m kh\u00eda c\u1ea1nh c\u1ee5 th\u1ec3: \u0111a d\u1ea1ng h\u00f3a doanh thu (58,5 t\u1ef7 USD v\u00e0o n\u0103m 2023), ti\u1ec1m n\u0103ng \u0111\u01b0\u1eddng \u1ed1ng (43 \u1ee9ng vi\u00ean Giai \u0111o\u1ea1n 3), t\u00ednh b\u1ec1n v\u1eefng c\u1ee7a c\u1ed5 t\u1ee9c (14 n\u0103m t\u0103ng tr\u01b0\u1edfng li\u00ean ti\u1ebfp), ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 (t\u1ef7 l\u1ec7 P\/E l\u00e0 12,7), v\u00e0 c\u00e1c ch\u1ec9 s\u1ed1 k\u1ef9 thu\u1eadt tr\u00ean n\u1ec1n t\u1ea3ng ph\u00e2n t\u00edch c\u1ee7a Pocket Option.\n\nKhi c\u00e1c nh\u00e0 giao d\u1ecbch tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng nh\u01b0 Pocket Option ph\u00e2n t\u00edch c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m, h\u1ecd xem x\u00e9t m\u1ed9t s\u1ed1 y\u1ebfu t\u1ed1 quan tr\u1ecdng: d\u00f2ng doanh thu, ti\u1ec1m n\u0103ng \u0111\u01b0\u1eddng \u1ed1ng, t\u00ednh b\u1ec1n v\u1eefng c\u1ee7a c\u1ed5 t\u1ee9c v\u00e0 ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1. Pfizer, v\u1edbi di s\u1ea3n 173 n\u0103m b\u1eaft \u0111\u1ea7u t\u1eeb thu\u1ed1c ch\u1ed1ng k\u00fd sinh tr\u00f9ng ti\u00ean phong c\u1ee7a Charles Pfizer v\u00e0o n\u0103m 1849, l\u00e0 m\u1ed9t nghi\u00ean c\u1ee9u tr\u01b0\u1eddng h\u1ee3p \u0111\u1eb7c bi\u1ec7t th\u00fa v\u1ecb cho c\u1ea3 nh\u00e0 \u0111\u1ea7u t\u01b0 ph\u00f2ng th\u1ee7 v\u00e0 \u0111\u1ecbnh h\u01b0\u1edbng t\u0103ng tr\u01b0\u1edfng.\n<h2>S\u1ee9c Kh\u1ecfe T\u00e0i Ch\u00ednh C\u1ee7a Pfizer: Kh\u00e1m Ph\u00e1 S\u00e2u V\u00e0o C\u00e1c Con S\u1ed1<\/h2>\nTr\u01b0\u1edbc khi x\u00e1c \u0111\u1ecbnh li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua hay kh\u00f4ng, vi\u1ec7c xem x\u00e9t n\u1ec1n t\u1ea3ng t\u00e0i ch\u00ednh c\u1ee7a n\u00f3 cung c\u1ea5p b\u1ed1i c\u1ea3nh c\u1ea7n thi\u1ebft. C\u00f4ng ty \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 t\u0103ng tr\u01b0\u1edfng doanh thu k\u1ef7 l\u1ee5c t\u1eeb 41,9 t\u1ef7 USD v\u00e0o n\u0103m 2020 l\u00ean 81,3 t\u1ef7 USD v\u00e0o n\u0103m 2022, tr\u01b0\u1edbc khi b\u00ecnh th\u01b0\u1eddng h\u00f3a xu\u1ed1ng 58,5 t\u1ef7 USD v\u00e0o n\u0103m 2023, \u0111\u1eb7c bi\u1ec7t sau c\u00e1c s\u1ea3n ph\u1ea9m li\u00ean quan \u0111\u1ebfn \u0111\u1ea1i d\u1ecbch t\u1ea1o ra d\u00f2ng ti\u1ec1n ch\u01b0a t\u1eebng c\u00f3.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Ch\u1ec9 S\u1ed1 T\u00e0i Ch\u00ednh<\/th>\n<th>Gi\u00e1 Tr\u1ecb 2023<\/th>\n<th>D\u1ef1 B\u00e1o 2024<\/th>\n<th>Xu H\u01b0\u1edbng 5 N\u0103m<\/th>\n<th>so v\u1edbi Trung B\u00ecnh Ng\u00e0nh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Doanh Thu<\/td>\n<td>58,5 t\u1ef7 USD<\/td>\n<td>61,4 t\u1ef7 USD<\/td>\n<td>\u1ed4n \u0111\u1ecbnh sau \u0111\u1ec9nh COVID<\/td>\n<td>+7,3%<\/td>\n<\/tr>\n<tr>\n<td>L\u1ee3i Nhu\u1eadn R\u00f2ng<\/td>\n<td>10,2 t\u1ef7 USD<\/td>\n<td>11,7 t\u1ef7 USD<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng v\u1eeba ph\u1ea3i<\/td>\n<td>+4,8%<\/td>\n<\/tr>\n<tr>\n<td>L\u1ee3i Su\u1ea5t C\u1ed5 T\u1ee9c<\/td>\n<td>5,4%<\/td>\n<td>5,6% (\u01b0\u1edbc t\u00ednh)<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng li\u00ean t\u1ee5c<\/td>\n<td>+2,6%<\/td>\n<\/tr>\n<tr>\n<td>T\u1ef7 L\u1ec7 P\/E<\/td>\n<td>13,2<\/td>\n<td>12,7 (d\u1ef1 ki\u1ebfn)<\/td>\n<td>D\u01b0\u1edbi trung b\u00ecnh ng\u00e0nh<\/td>\n<td>-15,3%<\/td>\n<\/tr>\n<tr>\n<td>D\u00f2ng Ti\u1ec1n T\u1ef1 Do<\/td>\n<td>18,3 t\u1ef7 USD<\/td>\n<td>19,7 t\u1ef7 USD<\/td>\n<td>M\u1ea1nh m\u1ebd v\u00e0 b\u1ec1n v\u1eefng<\/td>\n<td>+12,5%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nC\u00e1c ch\u1ec9 s\u1ed1 t\u00e0i ch\u00ednh n\u00e0y ti\u1ebft l\u1ed9 m\u1ed9t c\u00f4ng ty c\u00f3 d\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t \u0111\u00e1ng k\u1ec3, cho ph\u00e9p c\u00e1c s\u00e1ng ki\u1ebfn chi\u1ebfn l\u01b0\u1ee3c c\u00f3 th\u1ec3 n\u00e2ng cao t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai. C\u00f4ng c\u1ee5 s\u00e0ng l\u1ecdc c\u1ed5 phi\u1ebfu t\u00f9y ch\u1ec9nh c\u1ee7a Pocket Option n\u1ed5i b\u1eadt PFE v\u1edbi m\u1ee9c chi\u1ebft kh\u1ea5u gi\u00e1 tr\u00ean thu nh\u1eadp 27% so v\u1edbi trung b\u00ecnh ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m, cho th\u1ea5y s\u1ef1 \u0111\u1ecbnh gi\u00e1 th\u1ea5p \u0111\u00e1ng k\u1ec3 khi xem x\u00e9t kh\u1ea3 n\u0103ng t\u1ea1o ti\u1ec1n m\u1eb7t h\u00e0ng \u0111\u1ea7u c\u1ee7a ng\u00e0nh l\u00e0 18,3 t\u1ef7 USD h\u00e0ng n\u0103m.\n<h3>L\u1ee3i Th\u1ebf C\u1ed5 T\u1ee9c: Ti\u1ec1m N\u0103ng T\u1ea1o Thu Nh\u1eadp<\/h3>\nM\u1ed9t l\u00fd do h\u1ea5p d\u1eabn khi\u1ebfn nhi\u1ec1u nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00e2n nh\u1eafc Pfizer khi h\u1ecfi li\u1ec7u c\u1ed5 phi\u1ebfu PFE c\u00f3 \u0111\u00e1ng mua li\u00ean quan \u0111\u1ebfn h\u1ed3 s\u01a1 c\u1ed5 t\u1ee9c c\u1ee7a n\u00f3, x\u1ebfp h\u1ea1ng trong top 3% c\u1ee7a t\u1ea5t c\u1ea3 c\u00e1c c\u1ed5 phi\u1ebfu S&P 500 theo l\u1ee3i su\u1ea5t. V\u1edbi l\u1ee3i su\u1ea5t v\u01b0\u1ee3t qu\u00e1 5% \u1edf m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i, Pfizer n\u1eb1m trong s\u1ed1 nh\u1eefng nh\u00e0 tr\u1ea3 c\u1ed5 t\u1ee9c h\u00e0o ph\u00f3ng nh\u1ea5t c\u1ee7a ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Kh\u00eda C\u1ea1nh C\u1ed5 T\u1ee9c<\/th>\n<th>Hi\u1ec7u Su\u1ea5t Pfizer<\/th>\n<th>Trung B\u00ecnh Ng\u00e0nh<\/th>\n<th>L\u1ee3i Th\u1ebf<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>L\u1ee3i Su\u1ea5t Hi\u1ec7n T\u1ea1i<\/td>\n<td>5,4%<\/td>\n<td>2,8%<\/td>\n<td>+2,6%<\/td>\n<\/tr>\n<tr>\n<td>T\u1ef7 L\u1ec7 T\u0103ng Tr\u01b0\u1edfng C\u1ed5 T\u1ee9c (5 n\u0103m)<\/td>\n<td>3,7% h\u00e0ng n\u0103m<\/td>\n<td>2,9% h\u00e0ng n\u0103m<\/td>\n<td>+0,8%<\/td>\n<\/tr>\n<tr>\n<td>T\u1ef7 L\u1ec7 Chi Tr\u1ea3<\/td>\n<td>65%<\/td>\n<td>52%<\/td>\n<td>+13%<\/td>\n<\/tr>\n<tr>\n<td>T\u00ednh Nh\u1ea5t Qu\u00e1n C\u1ed5 T\u1ee9c<\/td>\n<td>14 n\u0103m t\u0103ng li\u00ean ti\u1ebfp<\/td>\n<td>8,3 n\u0103m trung b\u00ecnh<\/td>\n<td>+5,7 n\u0103m<\/td>\n<\/tr>\n<tr>\n<td>Thu Nh\u1eadp H\u00e0ng N\u0103m tr\u00ean 10.000 USD<\/td>\n<td>540 USD<\/td>\n<td>280 USD<\/td>\n<td>+260 USD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nH\u1ed3 s\u01a1 c\u1ed5 t\u1ee9c n\u00e0y l\u00e0m cho Pfizer \u0111\u1eb7c bi\u1ec7t h\u1ea5p d\u1eabn \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u1eadp trung v\u00e0o thu nh\u1eadp, \u0111\u1eb7c bi\u1ec7t trong c\u00e1c giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt tr\u00ean Pocket Option th\u01b0\u1eddng nh\u1ea5n m\u1ea1nh d\u00f2ng thu nh\u1eadp \u1ed5n \u0111\u1ecbnh n\u00e0y nh\u01b0 thi\u1ebft l\u1eadp m\u1ed9t m\u1ee9c h\u1ed7 tr\u1ee3 l\u00fd thuy\u1ebft \u1edf kho\u1ea3ng 30 USD d\u1ef1a tr\u00ean c\u00e1c m\u1ee9c tr\u1ea7n l\u1ee3i su\u1ea5t l\u1ecbch s\u1eed l\u00e0 6,2%, nh\u01b0 \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh b\u1edfi c\u00e1c c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch l\u1ee3i su\u1ea5t c\u1ee7a Pocket Option.\n<h2>Ti\u1ec1m N\u0103ng \u0110\u01b0\u1eddng \u1ed0ng: Ch\u1ea5t X\u00fac T\u00e1c Doanh Thu T\u01b0\u01a1ng Lai<\/h2>\nKhi xem x\u00e9t li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua hay kh\u00f4ng, c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tinh vi nh\u00ecn xa h\u01a1n c\u00e1c t\u00e0i ch\u00ednh hi\u1ec7n t\u1ea1i \u0111\u1ec3 \u0111\u00e1nh gi\u00e1 c\u00e1c \u0111\u1ed9ng l\u1ef1c t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai. \u0110\u01b0\u1eddng \u1ed1ng nghi\u00ean c\u1ee9u v\u00e0 ph\u00e1t tri\u1ec3n c\u1ee7a Pfizer ch\u1ee9a 26 \u1ee9ng vi\u00ean giai \u0111o\u1ea1n cu\u1ed1i (Giai \u0111o\u1ea1n 2\/3) trong c\u00e1c l\u0129nh v\u1ef1c ung th\u01b0, mi\u1ec5n d\u1ecbch h\u1ecdc v\u00e0 b\u1ec7nh hi\u1ebfm g\u1eb7p c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u00e1ng k\u1ec3 \u0111\u1ebfn doanh thu trong t\u01b0\u01a1ng lai.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>L\u0129nh V\u1ef1c \u0110i\u1ec1u Tr\u1ecb<\/th>\n<th>\u1ee8ng Vi\u00ean \u0110\u01b0\u1eddng \u1ed0ng \u0110\u00e1ng Ch\u00fa \u00dd<\/th>\n<th>Quy M\u00f4 Th\u1ecb Tr\u01b0\u1eddng Ti\u1ec1m N\u0103ng<\/th>\n<th>Giai \u0110o\u1ea1n Ph\u00e1t Tri\u1ec3n<\/th>\n<th>T\u00e1c \u0110\u1ed9ng Doanh Thu D\u1ef1 Ki\u1ebfn (H\u00e0ng N\u0103m)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Ung Th\u01b0<\/td>\n<td>Elranatamab, Sasanlimab<\/td>\n<td>280 t\u1ef7 USD v\u00e0o n\u0103m 2027<\/td>\n<td>Giai \u0111o\u1ea1n 3, Giai \u0111o\u1ea1n 2<\/td>\n<td>3,8-4,5 t\u1ef7 USD<\/td>\n<\/tr>\n<tr>\n<td>Mi\u1ec5n D\u1ecbch H\u1ecdc<\/td>\n<td>Ritlecitinib, Brepocitinib<\/td>\n<td>150 t\u1ef7 USD v\u00e0o n\u0103m 2027<\/td>\n<td>Giai \u0111o\u1ea1n 3, Giai \u0111o\u1ea1n 2<\/td>\n<td>2,1-2,7 t\u1ef7 USD<\/td>\n<\/tr>\n<tr>\n<td>B\u1ec7nh Hi\u1ebfm G\u1eb7p<\/td>\n<td>Fordadistrogene movaparvovec<\/td>\n<td>180 t\u1ef7 USD v\u00e0o n\u0103m 2026<\/td>\n<td>Giai \u0111o\u1ea1n 3<\/td>\n<td>1,5-1,9 t\u1ef7 USD<\/td>\n<\/tr>\n<tr>\n<td>V\u1eafc-xin<\/td>\n<td>V\u1eafc-xin RSV, v\u1eafc-xin b\u1ec7nh Lyme<\/td>\n<td>120 t\u1ef7 USD v\u00e0o n\u0103m 2028<\/td>\n<td>Giai \u0111o\u1ea1n 3, Giai \u0111o\u1ea1n 2<\/td>\n<td>2,3-3,1 t\u1ef7 USD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\u0110\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd n\u00e0y tr\u1ef1c ti\u1ebfp gi\u1ea3i quy\u1ebft m\u1ed9t c\u00e2u h\u1ecfi quan tr\u1ecdng cho nh\u1eefng ng\u01b0\u1eddi t\u1ef1 h\u1ecfi li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua - ti\u1ec1m n\u0103ng c\u1ee7a c\u00f4ng ty cho t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai v\u01b0\u1ee3t ra ngo\u00e0i c\u00e1c s\u1ea3n ph\u1ea9m \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp. \u0110\u1ea7u t\u01b0 R&D \u0111\u00e1ng k\u1ec3 c\u1ee7a Pfizer (11,8 t\u1ef7 USD v\u00e0o n\u0103m 2023, chi\u1ebfm 20,2% doanh thu) th\u00fac \u0111\u1ea9y \u0111\u01b0\u1eddng \u1ed1ng n\u00e0y, \u0111\u1ecbnh v\u1ecb c\u00f4ng ty \u0111\u1ec3 c\u00f3 th\u1ec3 chi\u1ebfm 15-20% th\u1ecb ph\u1ea7n trong th\u1ecb tr\u01b0\u1eddng ung th\u01b0 280 t\u1ef7 USD v\u00e0o n\u0103m 2028, theo s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.\n<h3>Th\u00e2u T\u00f3m Chi\u1ebfn L\u01b0\u1ee3c v\u00e0 Th\u00e0nh C\u00f4ng T\u00edch H\u1ee3p<\/h3>\nNgo\u00e0i ph\u00e1t tri\u1ec3n n\u1ed9i b\u1ed9, Pfizer \u0111\u00e3 th\u1ec3 hi\u1ec7n k\u1ef9 n\u0103ng trong c\u00e1c v\u1ee5 th\u00e2u t\u00f3m chi\u1ebfn l\u01b0\u1ee3c m\u1edf r\u1ed9ng s\u1ef1 hi\u1ec7n di\u1ec7n tr\u00ean th\u1ecb tr\u01b0\u1eddng. C\u00e1c v\u1ee5 th\u00e2u t\u00f3m g\u1ea7n \u0111\u00e2y bao g\u1ed3m:\n<ul>\n \t<li>Seagen (2023, 43 t\u1ef7 USD) \u2013 M\u1edf r\u1ed9ng danh m\u1ee5c ung th\u01b0 v\u1edbi c\u00f4ng ngh\u1ec7 li\u00ean h\u1ee3p thu\u1ed1c kh\u00e1ng th\u1ec3; \u0111\u00f3ng g\u00f3p 650 tri\u1ec7u USD doanh thu qu\u00fd 1 n\u0103m 2024, v\u01b0\u1ee3t 12% so v\u1edbi k\u1ef3 v\u1ecdng<\/li>\n \t<li>Arena Pharmaceuticals (2022, 6,7 t\u1ef7 USD) \u2013 T\u0103ng c\u01b0\u1eddng \u0111\u01b0\u1eddng \u1ed1ng mi\u1ec5n d\u1ecbch h\u1ecdc v\u00e0 vi\u00eam nhi\u1ec5m; ph\u00ea duy\u1ec7t etrasimod v\u00e0o th\u00e1ng 3 n\u0103m 2024 v\u1edbi doanh s\u1ed1 \u0111\u1ec9nh d\u1ef1 ki\u1ebfn 3,1 t\u1ef7 USD<\/li>\n \t<li>Trillium Therapeutics (2021, 2,3 t\u1ef7 USD) \u2013 T\u0103ng c\u01b0\u1eddng kh\u1ea3 n\u0103ng ung th\u01b0; TTI-622 cho th\u1ea5y t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng 37% trong c\u00e1c b\u1ec7nh ung th\u01b0 m\u00e1u kh\u00f3 \u0111i\u1ec1u tr\u1ecb<\/li>\n \t<li>ReViral (2022, 525 tri\u1ec7u USD) \u2013 Th\u00eam c\u00e1c li\u1ec7u ph\u00e1p RSV; th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2 cho th\u1ea5y gi\u1ea3m 86% t\u1ea3i l\u01b0\u1ee3ng virus so v\u1edbi gi\u1ea3 d\u01b0\u1ee3c<\/li>\n<\/ul>\nC\u00e1c v\u1ee5 th\u00e2u t\u00f3m n\u00e0y ph\u1ea3n \u00e1nh chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Pfizer trong vi\u1ec7c b\u1ed5 sung t\u0103ng tr\u01b0\u1edfng h\u1eefu c\u01a1 b\u1eb1ng c\u00e1c v\u1ee5 mua l\u1ea1i c\u00f3 m\u1ee5c ti\u00eau c\u00e1c c\u00f4ng ngh\u1ec7 s\u00e1ng t\u1ea1o v\u00e0 t\u00e0i s\u1ea3n \u0111\u01b0\u1eddng \u1ed1ng. \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch c\u1ee7a Pocket Option, c\u00e1c \u0111\u1ed9ng th\u00e1i chi\u1ebfn l\u01b0\u1ee3c n\u00e0y cung c\u1ea5p s\u1ef1 t\u1ef1 tin c\u00f3 th\u1ec3 \u0111\u1ecbnh l\u01b0\u1ee3ng th\u00f4ng qua ROI c\u00f3 th\u1ec3 ch\u1ee9ng minh tr\u00ean c\u00e1c v\u1ee5 th\u00e2u t\u00f3m tr\u01b0\u1edbc \u0111\u00f3 trung b\u00ecnh 13,7% h\u00e0ng n\u0103m trong c\u00e1c giai \u0111o\u1ea1n 5 n\u0103m.\n<h2>C\u00e2u Chuy\u1ec7n Th\u00e0nh C\u00f4ng C\u1ee7a Nh\u00e0 \u0110\u1ea7u T\u01b0: K\u1ebft Qu\u1ea3 \u0110\u1ea7u T\u01b0 Th\u1ef1c T\u1ebf V\u00e0o PFE<\/h2>\nHi\u1ec3u \u0111\u01b0\u1ee3c gi\u00e1 tr\u1ecb \u0111\u1ea7u t\u01b0 l\u00fd thuy\u1ebft l\u00e0 c\u00f3 gi\u00e1 tr\u1ecb, nh\u01b0ng vi\u1ec7c xem x\u00e9t c\u00e1c tr\u1ea3i nghi\u1ec7m th\u1ef1c t\u1ebf c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 cung c\u1ea5p b\u1ed1i c\u1ea3nh th\u1ef1c t\u1ebf khi x\u00e1c \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua. C\u00e1c tr\u01b0\u1eddng h\u1ee3p sau \u0111\u00e2y minh h\u1ecda c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn v\u00e0 k\u1ebft qu\u1ea3 \u0111\u1ea7u t\u01b0 kh\u00e1c nhau.\n<h3>Nghi\u00ean C\u1ee9u Tr\u01b0\u1eddng H\u1ee3p: Chi\u1ebfn L\u01b0\u1ee3c T\u00e1i \u0110\u1ea7u T\u01b0 C\u1ed5 T\u1ee9c<\/h3>\nMichael T., m\u1ed9t k\u1ef9 s\u01b0 \u0111\u00e3 ngh\u1ec9 h\u01b0u 58 tu\u1ed5i, \u0111\u00e3 th\u1ef1c hi\u1ec7n m\u1ed9t k\u1ebf ho\u1ea1ch t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c (DRIP) v\u1edbi c\u1ed5 phi\u1ebfu Pfizer v\u00e0o n\u0103m 2011. Kho\u1ea3n \u0111\u1ea7u t\u01b0 ban \u0111\u1ea7u c\u1ee7a \u00f4ng l\u00e0 75.000 USD \u0111\u00e3 mua kho\u1ea3ng 3.900 c\u1ed5 phi\u1ebfu v\u1edbi gi\u00e1 trung b\u00ecnh 19,23 USD m\u1ed7i c\u1ed5 phi\u1ebfu.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>N\u0103m<\/th>\n<th>C\u1ed5 Phi\u1ebfu S\u1edf H\u1eefu<\/th>\n<th>C\u1ed5 T\u1ee9c H\u00e0ng N\u0103m Nh\u1eadn \u0110\u01b0\u1ee3c<\/th>\n<th>T\u1ed5ng Gi\u00e1 Tr\u1ecb \u0110\u1ea7u T\u01b0<\/th>\n<th>C\u1ed5 T\u1ee9c T\u00edch L\u0169y<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2011<\/td>\n<td>3.900<\/td>\n<td>3.042 USD<\/td>\n<td>75.000 USD<\/td>\n<td>3.042 USD<\/td>\n<\/tr>\n<tr>\n<td>2015<\/td>\n<td>4.523<\/td>\n<td>5.066 USD<\/td>\n<td>146.545 USD<\/td>\n<td>17.358 USD<\/td>\n<\/tr>\n<tr>\n<td>2020<\/td>\n<td>5.687<\/td>\n<td>8.644 USD<\/td>\n<td>209.187 USD<\/td>\n<td>34.772 USD<\/td>\n<\/tr>\n<tr>\n<td>2024<\/td>\n<td>6.752<\/td>\n<td>12.153 USD<\/td>\n<td>236.320 USD<\/td>\n<td>55.947 USD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\"S\u1ef1 k\u1ebft h\u1ee3p gi\u1eefa t\u0103ng c\u1ed5 t\u1ee9c v\u00e0 t\u00e1i \u0111\u1ea7u t\u01b0 \u0111\u00e3 t\u1ea1o ra hi\u1ec7u \u1ee9ng l\u00e3i k\u00e9p l\u00e0m t\u0103ng \u0111\u00e1ng k\u1ec3 c\u1ea3 d\u00f2ng thu nh\u1eadp v\u00e0 k\u00edch th\u01b0\u1edbc v\u1ecb tr\u00ed t\u1ed5ng th\u1ec3 c\u1ee7a t\u00f4i,\" Michael gi\u1ea3i th\u00edch v\u1edbi c\u00e1c nh\u00e0 ph\u00e2n t\u00edch c\u1ee7a Pocket Option trong m\u1ed9t bu\u1ed5i t\u1ecda \u0111\u00e0m nh\u00e0 \u0111\u1ea7u t\u01b0. \"M\u1eb7c d\u00f9 gi\u00e1 c\u1ed5 phi\u1ebfu c\u1ee7a Pfizer \u0111\u00e3 tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng, c\u1ed5 t\u1ee9c ng\u00e0y c\u00e0ng t\u0103ng \u0111\u00e3 cung c\u1ea5p l\u1ee3i nhu\u1eadn \u1ed5n \u0111\u1ecbnh b\u1ea5t k\u1ec3 \u0111i\u1ec1u ki\u1ec7n th\u1ecb tr\u01b0\u1eddng, cho ph\u00e9p t\u00f4i t\u1ea1o ra 42.905 USD thu nh\u1eadp c\u1ed5 t\u1ee9c t\u1ed5ng c\u1ed9ng trong 13 n\u0103m trong khi t\u0103ng g\u1ea5p ba l\u1ea7n s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu c\u1ee7a m\u00ecnh.\"\n\nTr\u01b0\u1eddng h\u1ee3p n\u00e0y ch\u1ee9ng minh c\u00e1ch ch\u00ednh s\u00e1ch c\u1ed5 t\u1ee9c c\u1ee7a Pfizer c\u00f3 th\u1ec3 t\u1ea1o ra s\u1ef1 gi\u00e0u c\u00f3 \u0111\u00e1ng k\u1ec3 theo th\u1eddi gian, \u0111\u1eb7c bi\u1ec7t \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1eddi gian d\u00e0i h\u01a1n t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c trong c\u00e1c giai \u0111o\u1ea1n gi\u00e1 y\u1ebfu. Michael ghi nh\u1eadn c\u00f4ng c\u1ee5 t\u00ednh to\u00e1n t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c c\u1ee7a Pocket Option \u0111\u00e3 t\u1ed1i \u01b0u h\u00f3a k\u00edch th\u01b0\u1edbc v\u1ecb tr\u00ed c\u1ee7a \u00f4ng trong c\u00e1c \u0111\u1ee3t suy tho\u00e1i th\u1ecb tr\u01b0\u1eddng.\n<h2>Quan \u0110i\u1ec3m Ph\u00e2n T\u00edch K\u1ef9 Thu\u1eadt: \u0110i\u1ec3m V\u00e0o Cho C\u1ed5 Phi\u1ebfu PFE<\/h2>\n\u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 giao d\u1ecbch s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt c\u1ee7a Pocket Option, vi\u1ec7c x\u00e1c \u0111\u1ecbnh c\u00e1c \u0111i\u1ec3m v\u00e0o t\u1ed1i \u01b0u cho c\u1ed5 phi\u1ebfu Pfizer \u0111\u00f2i h\u1ecfi ph\u1ea3i xem x\u00e9t ba m\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt c\u1ee5 th\u1ec3 c\u00f3 \u00fd ngh\u0129a th\u1ed1ng k\u00ea \u0111\u1ed1i v\u1edbi c\u00e1c chuy\u1ec3n \u0111\u1ed9ng c\u1ed5 phi\u1ebfu PFE: \u0111\u00e1y \u0111\u00f4i, giao c\u1eaft v\u00e0ng, v\u00e0 ph\u00e2n k\u1ef3 RSI d\u01b0\u01a1ng. Ph\u00e2n t\u00edch l\u1ecbch s\u1eed ti\u1ebft l\u1ed9 c\u00e1c m\u00f4 h\u00ecnh n\u00e0y \u0111\u00e3 b\u00e1o tr\u01b0\u1edbc c\u00e1c chuy\u1ec3n \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3 cho PFE.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>M\u00f4 H\u00ecnh K\u1ef9 Thu\u1eadt<\/th>\n<th>Xu\u1ea5t Hi\u1ec7n L\u1ecbch S\u1eed<\/th>\n<th>K\u1ebft Qu\u1ea3 Th\u00f4ng Th\u01b0\u1eddng<\/th>\n<th>Tr\u1ea1ng Th\u00e1i Hi\u1ec7n T\u1ea1i<\/th>\n<th>T\u1ef7 L\u1ec7 Th\u00e0nh C\u00f4ng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u0110\u00e1y \u0110\u00f4i<\/td>\n<td>4 l\u1ea7n trong th\u1eadp k\u1ef7 qua<\/td>\n<td>T\u0103ng trung b\u00ecnh 17% trong v\u00f2ng 6 th\u00e1ng<\/td>\n<td>\u0110ang h\u00ecnh th\u00e0nh (12 th\u00e1ng 3, 2025)<\/td>\n<td>75%<\/td>\n<\/tr>\n<tr>\n<td>Giao C\u1eaft V\u00e0ng (MA 50 ng\u00e0y c\u1eaft tr\u00ean MA 200 ng\u00e0y)<\/td>\n<td>6 l\u1ea7n xu\u1ea5t hi\u1ec7n t\u1eeb n\u0103m 2014<\/td>\n<td>T\u0103ng trung b\u00ecnh 12% trong qu\u00fd ti\u1ebfp theo<\/td>\n<td>\u0110ang ti\u1ebfp c\u1eadn (D\u1ef1 ki\u1ebfn 28 th\u00e1ng 4, 2025)<\/td>\n<td>83%<\/td>\n<\/tr>\n<tr>\n<td>Ph\u00e2n K\u1ef3 RSI (d\u01b0\u01a1ng)<\/td>\n<td>9 l\u1ea7n xu\u1ea5t hi\u1ec7n t\u1eeb n\u0103m 2015<\/td>\n<td>T\u0103ng trung b\u00ecnh 8% trong v\u00f2ng 45 ng\u00e0y<\/td>\n<td>Hi\u1ec7n t\u1ea1i (T\u1eeb 22 th\u00e1ng 2, 2025)<\/td>\n<td>67%<\/td>\n<\/tr>\n<tr>\n<td>T\u00edch L\u0169y Kh\u1ed1i L\u01b0\u1ee3ng<\/td>\n<td>M\u00f4 h\u00ecnh nh\u1ea5t qu\u00e1n tr\u01b0\u1edbc c\u00e1c \u0111\u1ee3t t\u0103ng m\u1ea1nh<\/td>\n<td>B\u00e1o tr\u01b0\u1edbc c\u00e1c xu h\u01b0\u1edbng t\u0103ng b\u1ec1n v\u1eefng<\/td>\n<td>Giai \u0111o\u1ea1n \u0111\u1ea7u (14 ng\u00e0y ho\u00e0n th\u00e0nh)<\/td>\n<td>71%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nC\u00e1c nh\u00e0 giao d\u1ecbch k\u1ef9 thu\u1eadt tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng Pocket Option \u0111\u00e3 x\u00e1c \u0111\u1ecbnh c\u00e1c m\u00f4 h\u00ecnh n\u00e0y l\u00e0 c\u00e1c ch\u1ec9 b\u00e1o c\u00f3 th\u1ec3 h\u1eefu \u00edch khi \u0111\u1ecbnh th\u1eddi \u0111i\u1ec3m v\u00e0o v\u1ecb tr\u00ed PFE. Theo ph\u00e2n t\u00edch m\u00f4 h\u00ecnh l\u1ecbch s\u1eed tr\u00ean b\u1ea3ng \u0111i\u1ec1u khi\u1ec3n k\u1ef9 thu\u1eadt c\u1ee7a Pocket Option, m\u00f4 h\u00ecnh \u0111\u00e1y \u0111\u00f4i hi\u1ec7n t\u1ea1i \u0111ang h\u00ecnh th\u00e0nh c\u00f3 x\u00e1c su\u1ea5t 73% d\u1eabn \u0111\u1ebfn t\u0103ng gi\u00e1 12-17% trong v\u00f2ng 120 ng\u00e0y. Tuy nhi\u00ean, h\u1ecd nh\u1ea5n m\u1ea1nh r\u1eb1ng ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt n\u00ean b\u1ed5 sung, kh\u00f4ng thay th\u1ebf, ph\u00e2n t\u00edch c\u01a1 b\u1ea3n khi \u0111\u00e1nh gi\u00e1 li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua cho chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 c\u1ee5 th\u1ec3 c\u1ee7a b\u1ea1n.\n<h2>\u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: Th\u00e1ch Th\u1ee9c \u0110\u1ed1i M\u1eb7t V\u1edbi Pfizer<\/h2>\nPh\u00e2n t\u00edch \u0111\u1ea7u t\u01b0 th\u1eadn tr\u1ecdng \u0111\u00f2i h\u1ecfi ph\u1ea3i xem x\u00e9t c\u00e1c r\u1ee7i ro ti\u1ec1m \u1ea9n c\u00f9ng v\u1edbi c\u00e1c c\u01a1 h\u1ed9i. M\u1ed9t s\u1ed1 th\u00e1ch th\u1ee9c c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn hi\u1ec7u su\u1ea5t c\u1ee7a Pfizer v\u00e0 n\u00ean \u0111\u01b0\u1ee3c xem x\u00e9t khi \u0111\u00e1nh gi\u00e1 li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua:\n<ul>\n \t<li>H\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf tr\u00ean c\u00e1c s\u1ea3n ph\u1ea9m ch\u00ednh t\u1ea1o ra v\u00e1ch \u0111\u00e1 doanh thu - t\u00e1c \u0111\u1ed9ng l\u1edbn nh\u1ea5t \u0111\u1ebfn Eliquis (2026, 4,8 t\u1ef7 USD doanh thu h\u00e0ng n\u0103m c\u00f3 nguy c\u01a1)<\/li>\n \t<li>\u00c1p l\u1ef1c gi\u00e1 ng\u00e0y c\u00e0ng t\u0103ng t\u1eeb c\u00e1c ch\u00ednh ph\u1ee7 v\u00e0 ng\u01b0\u1eddi tr\u1ea3 ti\u1ec1n tr\u00ean to\u00e0n c\u1ea7u - \u01b0\u1edbc t\u00ednh 3-5% \u00e1p l\u1ef1c gi\u00e1 h\u00e0ng n\u0103m<\/li>\n \t<li>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn ti\u1ebfn tr\u00ecnh \u0111\u01b0\u1eddng \u1ed1ng - \u1ea3nh h\u01b0\u1edfng l\u1ecbch s\u1eed \u0111\u1ebfn 27% \u1ee9ng vi\u00ean Giai \u0111o\u1ea1n 3<\/li>\n \t<li>Th\u00e1ch th\u1ee9c t\u00edch h\u1ee3p t\u1eeb c\u00e1c v\u1ee5 th\u00e2u t\u00f3m g\u1ea7n \u0111\u00e2y - Seagen c\u1ea7n 24-36 th\u00e1ng \u0111\u1ec3 th\u1ef1c hi\u1ec7n \u0111\u1ea7y \u0111\u1ee7 c\u00e1c hi\u1ec7p l\u1ef1c<\/li>\n \t<li>R\u1ee7i ro ki\u1ec7n t\u1ee5ng v\u1ed1n c\u00f3 trong ph\u00e1t tri\u1ec3n d\u01b0\u1ee3c ph\u1ea9m - hi\u1ec7n c\u00f3 3 v\u1ee5 ki\u1ec7n \u0111\u00e1ng k\u1ec3 v\u1edbi kh\u1ea3 n\u0103ng ph\u01a1i b\u00e0y 1,2 t\u1ef7 USD<\/li>\n<\/ul>\nC\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro n\u00e0y \u0111\u00e3 \u0111\u1ecbnh k\u1ef3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu c\u1ee7a Pfizer, t\u1ea1o ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng mang l\u1ea1i c\u1ea3 th\u00e1ch th\u1ee9c v\u00e0 c\u01a1 h\u1ed9i. C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 qu\u1ea3n l\u00fd r\u1ee7i ro c\u1ee7a Pocket Option th\u01b0\u1eddng th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c collar v\u1edbi c\u00e1c quy\u1ec1n ch\u1ecdn b\u1ea3o v\u1ec7 10-15% d\u01b0\u1edbi m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i \u0111\u1ec3 h\u1ea1n ch\u1ebf r\u1ee7i ro trong c\u00e1c th\u00f4ng b\u00e1o \u0111\u01b0\u1eddng \u1ed1ng.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Y\u1ebfu T\u1ed1 R\u1ee7i Ro<\/th>\n<th>T\u00e1c \u0110\u1ed9ng Ti\u1ec1m N\u0103ng<\/th>\n<th>Chi\u1ebfn L\u01b0\u1ee3c Gi\u1ea3m Thi\u1ec3u<\/th>\n<th>T\u00e1c \u0110\u1ed9ng L\u1ecbch S\u1eed \u0110\u1ebfn Gi\u00e1 C\u1ed5 Phi\u1ebfu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>V\u00e1ch \u0110\u00e1 B\u1eb1ng S\u00e1ng Ch\u1ebf<\/td>\n<td>Gi\u1ea3m doanh thu ti\u1ec1m n\u0103ng 15-20% cho c\u00e1c s\u1ea3n ph\u1ea9m b\u1ecb \u1ea3nh h\u01b0\u1edfng<\/td>\n<td>Ph\u00e1t tri\u1ec3n \u0111\u01b0\u1eddng \u1ed1ng, qu\u1ea3n l\u00fd v\u00f2ng \u0111\u1eddi, th\u00e2u t\u00f3m chi\u1ebfn l\u01b0\u1ee3c<\/td>\n<td>-8% \u0111\u1ebfn -12% trong c\u00e1c tr\u01b0\u1eddng h\u1ee3p l\u1ecbch s\u1eed t\u01b0\u01a1ng t\u1ef1<\/td>\n<\/tr>\n<tr>\n<td>\u00c1p L\u1ef1c Gi\u00e1<\/td>\n<td>Gi\u1ea3m bi\u00ean l\u1ee3i nhu\u1eadn, \u0111\u1eb7c bi\u1ec7t \u1edf c\u00e1c th\u1ecb tr\u01b0\u1eddng ph\u00e1t tri\u1ec3n<\/td>\n<td>\u0110a d\u1ea1ng h\u00f3a \u0111\u1ecba l\u00fd, m\u00f4 h\u00ecnh \u0111\u1ecbnh gi\u00e1 d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb<\/td>\n<td>-3% \u0111\u1ebfn -5% sau c\u00e1c th\u00f4ng b\u00e1o quy \u0111\u1ecbnh<\/td>\n<\/tr>\n<tr>\n<td>N\u0103ng Su\u1ea5t R&D<\/td>\n<td>Chi ph\u00ed cao h\u01a1n, t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng th\u1ea5p h\u01a1n \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai<\/td>\n<td>H\u1ee3p t\u00e1c b\u00ean ngo\u00e0i, kh\u00e1m ph\u00e1 d\u1ef1a tr\u00ean AI, c\u00e1c l\u0129nh v\u1ef1c \u0111i\u1ec1u tr\u1ecb t\u1eadp trung<\/td>\n<td>-5% \u0111\u1ebfn -15% khi th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u1edbn<\/td>\n<\/tr>\n<tr>\n<td>M\u00f4i Tr\u01b0\u1eddng Quy \u0110\u1ecbnh<\/td>\n<td>Tr\u00ec ho\u00e3n ph\u00ea duy\u1ec7t, y\u00eau c\u1ea7u nghi\u00ean c\u1ee9u b\u1ed5 sung<\/td>\n<td>Tham gia quy \u0111\u1ecbnh s\u1edbm, thi\u1ebft k\u1ebf th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng m\u1ea1nh m\u1ebd<\/td>\n<td>-4% \u0111\u1ebfn -7% khi g\u1eb7p tr\u1edf ng\u1ea1i quy \u0111\u1ecbnh<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Chi\u1ebfn L\u01b0\u1ee3c \u0110\u1ea7u T\u01b0: C\u00e1ch Ti\u1ebfp C\u1eadn V\u1ecb Tr\u00ed PFE<\/h2>\nC\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 kh\u00e1c nhau \u0111\u00e3 th\u00e0nh c\u00f4ng trong vi\u1ec7c th\u1ef1c hi\u1ec7n c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn kh\u00e1c nhau \u0111\u1ed1i v\u1edbi v\u1ecb tr\u00ed c\u1ed5 phi\u1ebfu Pfizer, m\u1ed7i c\u00e1ch ph\u00f9 h\u1ee3p v\u1edbi c\u00e1c m\u1ee5c ti\u00eau t\u00e0i ch\u00ednh c\u1ee5 th\u1ec3 v\u00e0 kh\u1ea3 n\u0103ng ch\u1ecbu r\u1ee7i ro. Khi xem x\u00e9t li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua cho danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n, vi\u1ec7c xem x\u00e9t c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn chi\u1ebfn l\u01b0\u1ee3c n\u00e0y cung c\u1ea5p g\u00f3c nh\u00ecn c\u00f3 gi\u00e1 tr\u1ecb.\n<h3>Chi\u1ebfn L\u01b0\u1ee3c T\u00edch L\u0169y D\u1ef1a Tr\u00ean Gi\u00e1 Tr\u1ecb<\/h3>\nSarah K., m\u1ed9t nh\u00e0 qu\u1ea3n l\u00fd danh m\u1ee5c \u0111\u1ea7u t\u01b0 v\u1edbi 20 n\u0103m kinh nghi\u1ec7m, \u0111\u00e3 chia s\u1ebb c\u00e1ch ti\u1ebfp c\u1eadn d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb c\u1ee7a m\u00ecnh \u0111\u1ed1i v\u1edbi Pfizer v\u1edbi c\u00e1c nh\u00e0 ph\u00e2n t\u00edch c\u1ee7a Pocket Option: \"Ch\u00fang t\u00f4i th\u1ef1c hi\u1ec7n m\u1ed9t ch\u01b0\u01a1ng tr\u00ecnh mua c\u00f3 h\u1ec7 th\u1ed1ng cho PFE khi l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a n\u00f3 v\u01b0\u1ee3t qu\u00e1 4,5% v\u00e0 t\u1ef7 l\u1ec7 P\/E c\u1ee7a n\u00f3 th\u1ea5p h\u01a1n trung b\u00ecnh ng\u00e0nh. C\u00e1ch ti\u1ebfp c\u1eadn d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb n\u00e0y \u0111\u00e3 li\u00ean t\u1ee5c t\u1ea1o ra alpha trong c\u00e1c giai \u0111o\u1ea1n n\u1eafm gi\u1eef 5 n\u0103m.\"\n\nPh\u01b0\u01a1ng ph\u00e1p c\u1ee7a nh\u00f3m c\u00f4 bao g\u1ed3m:\n<ul>\n \t<li>Ph\u00e2n b\u1ed5 25% v\u1ecb tr\u00ed d\u1ef1 \u0111\u1ecbnh khi c\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 \u0111\u1ea7u ti\u00ean k\u00edch ho\u1ea1t t\u00edn hi\u1ec7u mua (P\/E d\u01b0\u1edbi 13, l\u1ee3i su\u1ea5t tr\u00ean 4,5%)<\/li>\n \t<li>Th\u00eam 25% khi gi\u00e1 gi\u1ea3m th\u00eam 5% n\u1ebfu c\u00e1c y\u1ebfu t\u1ed1 c\u01a1 b\u1ea3n kh\u00f4ng thay \u0111\u1ed5i, \u0111\u1ea1t \u0111\u01b0\u1ee3c l\u1ee3i \u00edch trung b\u00ecnh chi ph\u00ed<\/li>\n \t<li>Ho\u00e0n th\u00e0nh v\u1ecb tr\u00ed sau khi \u0111\u00e1nh gi\u00e1 k\u1ef9 l\u01b0\u1ee1ng c\u00e1c ph\u00e1t tri\u1ec3n \u0111\u01b0\u1eddng \u1ed1ng v\u00e0 th\u1ef1c thi qu\u1ea3n l\u00fd, th\u01b0\u1eddng trong v\u00f2ng 60-90 ng\u00e0y<\/li>\n \t<li>Th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c quy\u1ec1n ch\u1ecdn c\u00f3 b\u1ea3o hi\u1ec3m trong c\u00e1c giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng cao h\u01a1n \u0111\u1ec3 t\u0103ng l\u1ee3i su\u1ea5t th\u00eam 2-3% h\u00e0ng n\u0103m<\/li>\n<\/ul>\nC\u00e1ch ti\u1ebfp c\u1eadn c\u00f3 k\u1ef7 lu\u1eadt n\u00e0y \u0111\u00e3 cho ph\u00e9p kh\u00e1ch h\u00e0ng c\u1ee7a c\u00f4 x\u00e2y d\u1ef1ng c\u00e1c v\u1ecb tr\u00ed \u0111\u00e1ng k\u1ec3 trong Pfizer t\u1ea1i c\u00e1c \u0111i\u1ec3m v\u00e0o c\u00f3 l\u1ee3i, \u0111\u1ea1t \u0111\u01b0\u1ee3c c\u01a1 s\u1edf chi ph\u00ed trung b\u00ecnh th\u1ea5p h\u01a1n 18% so v\u1edbi gi\u00e1 th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i trong khi thu th\u1eadp 13.750 USD c\u1ed5 t\u1ee9c tr\u00ean m\u1ed7i 100.000 USD \u0111\u1ea7u t\u01b0 trong b\u1ed1n n\u0103m qua. Sarah \u0111\u1eb7c bi\u1ec7t s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 s\u00e0ng l\u1ecdc l\u1ee3i su\u1ea5t \u0111a khung th\u1eddi gian c\u1ee7a Pocket Option \u0111\u1ec3 x\u00e1c \u0111\u1ecbnh c\u00e1c \u0111i\u1ec3m v\u00e0o t\u1ed1i \u01b0u khi l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a Pfizer v\u01b0\u1ee3t qua c\u00e1c m\u1ee9c kh\u00e1ng c\u1ef1 l\u1ecbch s\u1eed.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Chi\u1ebfn L\u01b0\u1ee3c \u0110\u1ea7u T\u01b0<\/th>\n<th>Ph\u00f9 H\u1ee3p Nh\u1ea5t Cho<\/th>\n<th>K\u1ebft Qu\u1ea3 D\u1ef1 Ki\u1ebfn<\/th>\n<th>C\u00e1ch Ti\u1ebfp C\u1eadn Th\u1ef1c Hi\u1ec7n<\/th>\n<th>Hi\u1ec7u Su\u1ea5t L\u1ecbch S\u1eed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>T\u1eadp Trung V\u00e0o Thu Nh\u1eadp<\/td>\n<td>Ng\u01b0\u1eddi ngh\u1ec9 h\u01b0u, nh\u00e0 \u0111\u1ea7u t\u01b0 thu nh\u1eadp<\/td>\n<td>L\u1ee3i su\u1ea5t \u1ed5n \u0111\u1ecbnh 5%+ v\u1edbi t\u0103ng tr\u01b0\u1edfng v\u1eeba ph\u1ea3i<\/td>\n<td>V\u1ecb tr\u00ed \u0111\u1ea7y \u0111\u1ee7 v\u1edbi t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c<\/td>\n<td>L\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng h\u00e0ng n\u0103m 9,2% (2018-2024)<\/td>\n<\/tr>\n<tr>\n<td>T\u00edch L\u0169y Gi\u00e1 Tr\u1ecb<\/td>\n<td>Nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n ki\u00ean nh\u1eabn<\/td>\n<td>T\u0103ng gi\u00e1 v\u1ed1n trong 3-5 n\u0103m<\/td>\n<td>Mua theo giai \u0111o\u1ea1n d\u1ef1a tr\u00ean ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1<\/td>\n<td>L\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng h\u00e0ng n\u0103m 12,7% (2018-2024)<\/td>\n<\/tr>\n<tr>\n<td>Giao D\u1ecbch Ch\u1ea5t X\u00fac T\u00e1c<\/td>\n<td>Nh\u00e0 giao d\u1ecbch t\u00edch c\u1ef1c<\/td>\n<td>L\u1ee3i nhu\u1eadn 10-15% tr\u00ean c\u00e1c s\u1ef1 ki\u1ec7n tin t\u1ee9c t\u00edch c\u1ef1c<\/td>\n<td>Chi\u1ebfn l\u01b0\u1ee3c quy\u1ec1n ch\u1ecdn xung quanh c\u00e1c th\u00f4ng b\u00e1o d\u1eef li\u1ec7u<\/td>\n<td>18,3% m\u1ed7i giao d\u1ecbch, t\u1ef7 l\u1ec7 th\u1eafng 63%<\/td>\n<\/tr>\n<tr>\n<td>Ph\u00e2n B\u1ed5 Ng\u00e0nh<\/td>\n<td>Danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u00e2n b\u1eb1ng<\/td>\n<td>Ti\u1ebfp x\u00fac v\u1edbi ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe v\u1edbi \u0111\u1eb7c \u0111i\u1ec3m ph\u00f2ng th\u1ee7<\/td>\n<td>V\u1ecb tr\u00ed ti\u00eau chu\u1ea9n nh\u01b0 m\u1ed9t ph\u1ea7n c\u1ee7a tr\u1ecdng s\u1ed1 ng\u00e0nh<\/td>\n<td>L\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng h\u00e0ng n\u0103m 7,8% (2018-2024)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nC\u00e1c nh\u00e0 giao d\u1ecbch s\u1eed d\u1ee5ng c\u00e1c n\u1ec1n t\u1ea3ng Pocket Option th\u01b0\u1eddng th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c d\u1ef1a tr\u00ean quy\u1ec1n ch\u1ecdn xung quanh Pfizer, \u0111\u1eb7c bi\u1ec7t l\u00e0 tr\u01b0\u1edbc c\u00e1c th\u00f4ng b\u00e1o th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng l\u1edbn ho\u1eb7c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA. C\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn n\u00e0y c\u00f3 th\u1ec3 cung c\u1ea5p s\u1ef1 ti\u1ebfp x\u00fac \u0111\u00f2n b\u1ea9y v\u1edbi c\u00e1c chuy\u1ec3n \u0111\u1ed9ng gi\u00e1 trong khi x\u00e1c \u0111\u1ecbnh c\u00e1c tham s\u1ed1 r\u1ee7i ro ch\u00ednh x\u00e1c h\u01a1n so v\u1edbi s\u1edf h\u1eefu c\u1ed5 phi\u1ebfu tr\u1ef1c ti\u1ebfp.\n<h2>Ph\u00e2n T\u00edch So S\u00e1nh: PFE so v\u1edbi C\u00e1c \u0110\u1ed1i Th\u1ee7 D\u01b0\u1ee3c Ph\u1ea9m<\/h2>\nX\u00e1c \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua \u0111\u00f2i h\u1ecfi ph\u1ea3i \u0111\u1eb7t trong b\u1ed1i c\u1ea3nh c\u00e1c gi\u00e1 tr\u1ecb \u0111\u1ea7u t\u01b0 c\u1ee7a n\u00f3 so v\u1edbi c\u00e1c c\u00f4ng ty \u0111\u1ed3ng nghi\u1ec7p. Khung so s\u00e1nh n\u00e0y l\u00e0m n\u1ed5i b\u1eadt c\u00e1c \u0111i\u1ec3m m\u1ea1nh v\u00e0 \u0111i\u1ec3m y\u1ebfu t\u01b0\u01a1ng \u0111\u1ed1i c\u1ee7a Pfizer trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m.\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Ch\u1ec9 S\u1ed1<\/th>\n<th>Pfizer (PFE)<\/th>\n<th>Merck (MRK)<\/th>\n<th>Eli Lilly (LLY)<\/th>\n<th>Bristol Myers Squibb (BMY)<\/th>\n<th>Trung B\u00ecnh Ng\u00e0nh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>T\u1ef7 L\u1ec7 P\/E D\u1ef1 Ph\u00f3ng<\/td>\n<td>12,7<\/td>\n<td>14,9<\/td>\n<td>41,2<\/td>\n<td>8,6<\/td>\n<td>15,0<\/td>\n<\/tr>\n<tr>\n<td>L\u1ee3i Su\u1ea5t C\u1ed5 T\u1ee9c<\/td>\n<td>5,4%<\/td>\n<td>2,6%<\/td>\n<td>0,8%<\/td>\n<td>4,8%<\/td>\n<td>2,6%<\/td>\n<\/tr>\n<tr>\n<td>T\u0103ng Tr\u01b0\u1edfng Doanh Thu CAGR 5 N\u0103m<\/td>\n<td>7,2%<\/td>\n<td>6,8%<\/td>\n<td>12,4%<\/td>\n<td>5,7%<\/td>\n<td>6,4%<\/td>\n<\/tr>\n<tr>\n<td>R&D nh\u01b0 % Doanh Thu<\/td>\n<td>21,3%<\/td>\n<td>25,6%<\/td>\n<td>29,1%<\/td>\n<td>24,2%<\/td>\n<td>22,8%<\/td>\n<\/tr>\n<tr>\n<td>N\u1ee3 tr\u00ean EBITDA<\/td>\n<td>2,8<\/td>\n<td>1,9<\/td>\n<td>1,2<\/td>\n<td>3,2<\/td>\n<td>2,3<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\nSo s\u00e1nh n\u00e0y ti\u1ebft l\u1ed9 Pfizer cung c\u1ea5p l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c cao h\u01a1n 107% so v\u1edbi trung b\u00ecnh ng\u00e0nh (5,4% so v\u1edbi 2,6%) trong khi giao d\u1ecbch v\u1edbi m\u1ee9c chi\u1ebft kh\u1ea5u 15% so v\u1edbi t\u1ef7 l\u1ec7 P\/E trung b\u00ecnh c\u1ee7a \u0111\u1ed3ng nghi\u1ec7p (12,7 so v\u1edbi 15,0). \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 so s\u00e1nh ng\u00e0nh c\u1ee7a Pocket Option, PFE n\u1ed5i b\u1eadt v\u1edbi c\u00e1c ch\u1ec9 s\u1ed1 gi\u00e1 tr\u1ecb t\u01b0\u01a1ng \u0111\u1ed1i h\u1ea5p d\u1eabn, \u0111\u1eb7t n\u00f3 v\u00e0o nh\u00f3m tr\u00ean c\u00f9ng v\u1ec1 l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c v\u00e0 nh\u00f3m d\u01b0\u1edbi c\u00f9ng v\u1ec1 b\u1ed9i s\u1ed1 \u0111\u1ecbnh gi\u00e1 - m\u1ed9t s\u1ef1 k\u1ebft h\u1ee3p hi\u1ebfm hoi th\u01b0\u1eddng li\u00ean quan \u0111\u1ebfn c\u00e1c ch\u1ee9ng kho\u00e1n b\u1ecb \u0111\u1ecbnh gi\u00e1 th\u1ea5p.\n[cta_button text=\"B\u1eaft \u0110\u1ea7u Giao D\u1ecbch\"]\n<h2>K\u1ebft Lu\u1eadn: T\u1ed5ng H\u1ee3p Tr\u01b0\u1eddng H\u1ee3p \u0110\u1ea7u T\u01b0 Cho Pfizer<\/h2>\nC\u00e2u h\u1ecfi \"li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua\" cu\u1ed1i c\u00f9ng ph\u1ee5 thu\u1ed9c v\u00e0o c\u00e1c m\u1ee5c ti\u00eau \u0111\u1ea7u t\u01b0 c\u00e1 nh\u00e2n, th\u1eddi gian v\u00e0 b\u1ed1i c\u1ea3nh danh m\u1ee5c \u0111\u1ea7u t\u01b0. Tuy nhi\u00ean, m\u1ed9t s\u1ed1 quan s\u00e1t r\u00f5 r\u00e0ng n\u1ed5i l\u00ean t\u1eeb ph\u00e2n t\u00edch to\u00e0n di\u1ec7n n\u00e0y:\n\nPfizer tr\u00ecnh b\u00e0y m\u1ed9t \u0111\u1ec1 xu\u1ea5t gi\u00e1 tr\u1ecb h\u1ea5p d\u1eabn v\u1edbi l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c 5,4% v\u01b0\u1ee3t qu\u00e1 93% c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu S&P 500. C\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 hi\u1ec7n t\u1ea1i c\u1ee7a n\u00f3 cho th\u1ea5y s\u1ef1 \u0111\u1ecbnh gi\u00e1 th\u1ea5p 12% d\u1ef1a tr\u00ean c\u00e1c t\u1ef7 l\u1ec7 P\/E l\u1ecbch s\u1eed 5 n\u0103m v\u00e0 chi\u1ebft kh\u1ea5u 18% so v\u1edbi b\u1ed9i s\u1ed1 ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m, cung c\u1ea5p m\u1ed9t bi\u00ean \u0111\u1ed9 an to\u00e0n ti\u1ec1m n\u0103ng. \u0110\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd c\u1ee7a c\u00f4ng ty v\u00e0 c\u00e1ch ti\u1ebfp c\u1eadn th\u00e2u t\u00f3m chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ecbnh v\u1ecb n\u00f3 cho ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng v\u01b0\u1ee3t ra ngo\u00e0i danh m\u1ee5c s\u1ea3n ph\u1ea9m tr\u01b0\u1edfng th\u00e0nh c\u1ee7a n\u00f3.\n\n\u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng b\u1ed9 c\u00f4ng c\u1ee5 ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m to\u00e0n di\u1ec7n c\u1ee7a Pocket Option, Pfizer \u0111\u1ea1i di\u1ec7n cho m\u1ed9t l\u1ef1a ch\u1ecdn c\u00e2n b\u1eb1ng kh\u00e1ch quan v\u1edbi c\u00e1c ch\u1ec9 s\u1ed1 c\u00f3 th\u1ec3 \u0111\u1ecbnh l\u01b0\u1ee3ng: l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c nh\u00f3m tr\u00ean c\u00f9ng (5,4%), t\u1ef7 l\u1ec7 P\/E nh\u00f3m d\u01b0\u1edbi c\u00f9ng (12,7), v\u00e0 \u0111\u1ecbnh v\u1ecb \u0111\u01b0\u1eddng \u1ed1ng chi\u1ebfn l\u01b0\u1ee3c trong c\u00e1c th\u1ecb tr\u01b0\u1eddng ung th\u01b0 d\u1ef1 ki\u1ebfn t\u0103ng tr\u01b0\u1edfng v\u1edbi CAGR 14,2% \u0111\u1ebfn n\u0103m 2030. S\u1ee9c m\u1ea1nh t\u00e0i ch\u00ednh c\u1ee7a c\u00f4ng ty h\u1ed7 tr\u1ee3 c\u1ea3 vi\u1ec7c ti\u1ebfp t\u1ee5c thanh to\u00e1n c\u1ed5 t\u1ee9c v\u00e0 s\u1ef1 linh ho\u1ea1t chi\u1ebfn l\u01b0\u1ee3c cho ph\u00e1t tri\u1ec3n trong t\u01b0\u01a1ng lai. Trong khi \u0111\u1ed1i m\u1eb7t v\u1edbi c\u00e1c th\u00e1ch th\u1ee9c to\u00e0n ng\u00e0nh bao g\u1ed3m \u00e1p l\u1ef1c gi\u00e1 v\u00e0 h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf, quy m\u00f4 v\u00e0 \u0111a d\u1ea1ng h\u00f3a c\u1ee7a Pfizer cung c\u1ea5p c\u00e1c l\u1ee3i th\u1ebf c\u1ea1nh tranh c\u00f3 \u00fd ngh\u0129a.\n\nThay v\u00ec xem Pfizer ch\u1ec9 \u0111\u01a1n gi\u1ea3n l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu \u0111\u1ec3 mua ho\u1eb7c tr\u00e1nh, c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tinh vi c\u00f3 th\u1ec3 xem x\u00e9t th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u00e0o theo giai \u0111o\u1ea1n ho\u1eb7c c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn d\u1ef1a tr\u00ean quy\u1ec1n ch\u1ecdn \u0111\u1ec3 t\u1ed1i \u01b0u h\u00f3a s\u1ef1 ti\u1ebfp x\u00fac d\u1ef1a tr\u00ean \u0111\u1ecbnh gi\u00e1, t\u00edn hi\u1ec7u k\u1ef9 thu\u1eadt v\u00e0 ch\u1ea5t x\u00fac t\u00e1c \u0111\u01b0\u1eddng \u1ed1ng. \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm s\u1ef1 ti\u1ebfp x\u00fac v\u1edbi d\u01b0\u1ee3c ph\u1ea9m v\u1edbi c\u00e1c \u0111\u1eb7c \u0111i\u1ec3m thu nh\u1eadp, PFE \u0111\u00e1ng \u0111\u01b0\u1ee3c xem x\u00e9t cho m\u1ed9t ph\u00e2n b\u1ed5 danh m\u1ee5c \u0111\u1ea7u t\u01b0 3-5% nh\u01b0 m\u1ed9t ph\u1ea7n c\u1ed1t l\u00f5i c\u1ee7a danh m\u1ee5c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe, v\u1edbi c\u00e1c l\u1ea7n v\u00e0o theo giai \u0111o\u1ea1n t\u1ea1i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 k\u1ef9 thu\u1eadt c\u00f3 th\u1ec3 th\u1ea5y tr\u00ean c\u00e1c c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch \u0111a khung th\u1eddi gian c\u1ee7a Pocket Option.\n\n<\/div>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<div class=\"custom-html-container\">\n<h2>S\u1ef1 Thay \u0110\u1ed5i C\u1ee7a C\u1ea3nh Quan \u0110\u1ea7u T\u01b0 D\u01b0\u1ee3c Ph\u1ea9m<\/h2>\n<p>Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m t\u1eeb l\u00e2u \u0111\u00e3 mang \u0111\u1ebfn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1ed9t s\u1ef1 k\u1ebft h\u1ee3p \u0111\u1ed9c \u0111\u00e1o gi\u1eefa \u0111\u1eb7c \u0111i\u1ec3m ph\u00f2ng th\u1ee7 v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng. Trong b\u1ed1i c\u1ea3nh c\u1ea1nh tranh n\u00e0y, Pfizer Inc. (NYSE: PFE) \u0111\u1ee9ng th\u1ee9 4 trong s\u1ed1 c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m l\u1edbn nh\u1ea5t to\u00e0n c\u1ea7u theo doanh thu, v\u1edbi v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng v\u01b0\u1ee3t qu\u00e1 200 t\u1ef7 USD. C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u01b0\u1eddng h\u1ecfi: li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua trong m\u00f4i tr\u01b0\u1eddng th\u1ecb tr\u01b0\u1eddng hi\u1ec7n nay? C\u00e2u h\u1ecfi n\u00e0y \u0111\u00f2i h\u1ecfi ph\u1ea3i xem x\u00e9t n\u0103m kh\u00eda c\u1ea1nh c\u1ee5 th\u1ec3: \u0111a d\u1ea1ng h\u00f3a doanh thu (58,5 t\u1ef7 USD v\u00e0o n\u0103m 2023), ti\u1ec1m n\u0103ng \u0111\u01b0\u1eddng \u1ed1ng (43 \u1ee9ng vi\u00ean Giai \u0111o\u1ea1n 3), t\u00ednh b\u1ec1n v\u1eefng c\u1ee7a c\u1ed5 t\u1ee9c (14 n\u0103m t\u0103ng tr\u01b0\u1edfng li\u00ean ti\u1ebfp), ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 (t\u1ef7 l\u1ec7 P\/E l\u00e0 12,7), v\u00e0 c\u00e1c ch\u1ec9 s\u1ed1 k\u1ef9 thu\u1eadt tr\u00ean n\u1ec1n t\u1ea3ng ph\u00e2n t\u00edch c\u1ee7a Pocket Option.<\/p>\n<p>Khi c\u00e1c nh\u00e0 giao d\u1ecbch tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng nh\u01b0 Pocket Option ph\u00e2n t\u00edch c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m, h\u1ecd xem x\u00e9t m\u1ed9t s\u1ed1 y\u1ebfu t\u1ed1 quan tr\u1ecdng: d\u00f2ng doanh thu, ti\u1ec1m n\u0103ng \u0111\u01b0\u1eddng \u1ed1ng, t\u00ednh b\u1ec1n v\u1eefng c\u1ee7a c\u1ed5 t\u1ee9c v\u00e0 ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1. Pfizer, v\u1edbi di s\u1ea3n 173 n\u0103m b\u1eaft \u0111\u1ea7u t\u1eeb thu\u1ed1c ch\u1ed1ng k\u00fd sinh tr\u00f9ng ti\u00ean phong c\u1ee7a Charles Pfizer v\u00e0o n\u0103m 1849, l\u00e0 m\u1ed9t nghi\u00ean c\u1ee9u tr\u01b0\u1eddng h\u1ee3p \u0111\u1eb7c bi\u1ec7t th\u00fa v\u1ecb cho c\u1ea3 nh\u00e0 \u0111\u1ea7u t\u01b0 ph\u00f2ng th\u1ee7 v\u00e0 \u0111\u1ecbnh h\u01b0\u1edbng t\u0103ng tr\u01b0\u1edfng.<\/p>\n<h2>S\u1ee9c Kh\u1ecfe T\u00e0i Ch\u00ednh C\u1ee7a Pfizer: Kh\u00e1m Ph\u00e1 S\u00e2u V\u00e0o C\u00e1c Con S\u1ed1<\/h2>\n<p>Tr\u01b0\u1edbc khi x\u00e1c \u0111\u1ecbnh li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua hay kh\u00f4ng, vi\u1ec7c xem x\u00e9t n\u1ec1n t\u1ea3ng t\u00e0i ch\u00ednh c\u1ee7a n\u00f3 cung c\u1ea5p b\u1ed1i c\u1ea3nh c\u1ea7n thi\u1ebft. C\u00f4ng ty \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 t\u0103ng tr\u01b0\u1edfng doanh thu k\u1ef7 l\u1ee5c t\u1eeb 41,9 t\u1ef7 USD v\u00e0o n\u0103m 2020 l\u00ean 81,3 t\u1ef7 USD v\u00e0o n\u0103m 2022, tr\u01b0\u1edbc khi b\u00ecnh th\u01b0\u1eddng h\u00f3a xu\u1ed1ng 58,5 t\u1ef7 USD v\u00e0o n\u0103m 2023, \u0111\u1eb7c bi\u1ec7t sau c\u00e1c s\u1ea3n ph\u1ea9m li\u00ean quan \u0111\u1ebfn \u0111\u1ea1i d\u1ecbch t\u1ea1o ra d\u00f2ng ti\u1ec1n ch\u01b0a t\u1eebng c\u00f3.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Ch\u1ec9 S\u1ed1 T\u00e0i Ch\u00ednh<\/th>\n<th>Gi\u00e1 Tr\u1ecb 2023<\/th>\n<th>D\u1ef1 B\u00e1o 2024<\/th>\n<th>Xu H\u01b0\u1edbng 5 N\u0103m<\/th>\n<th>so v\u1edbi Trung B\u00ecnh Ng\u00e0nh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Doanh Thu<\/td>\n<td>58,5 t\u1ef7 USD<\/td>\n<td>61,4 t\u1ef7 USD<\/td>\n<td>\u1ed4n \u0111\u1ecbnh sau \u0111\u1ec9nh COVID<\/td>\n<td>+7,3%<\/td>\n<\/tr>\n<tr>\n<td>L\u1ee3i Nhu\u1eadn R\u00f2ng<\/td>\n<td>10,2 t\u1ef7 USD<\/td>\n<td>11,7 t\u1ef7 USD<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng v\u1eeba ph\u1ea3i<\/td>\n<td>+4,8%<\/td>\n<\/tr>\n<tr>\n<td>L\u1ee3i Su\u1ea5t C\u1ed5 T\u1ee9c<\/td>\n<td>5,4%<\/td>\n<td>5,6% (\u01b0\u1edbc t\u00ednh)<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng li\u00ean t\u1ee5c<\/td>\n<td>+2,6%<\/td>\n<\/tr>\n<tr>\n<td>T\u1ef7 L\u1ec7 P\/E<\/td>\n<td>13,2<\/td>\n<td>12,7 (d\u1ef1 ki\u1ebfn)<\/td>\n<td>D\u01b0\u1edbi trung b\u00ecnh ng\u00e0nh<\/td>\n<td>-15,3%<\/td>\n<\/tr>\n<tr>\n<td>D\u00f2ng Ti\u1ec1n T\u1ef1 Do<\/td>\n<td>18,3 t\u1ef7 USD<\/td>\n<td>19,7 t\u1ef7 USD<\/td>\n<td>M\u1ea1nh m\u1ebd v\u00e0 b\u1ec1n v\u1eefng<\/td>\n<td>+12,5%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>C\u00e1c ch\u1ec9 s\u1ed1 t\u00e0i ch\u00ednh n\u00e0y ti\u1ebft l\u1ed9 m\u1ed9t c\u00f4ng ty c\u00f3 d\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t \u0111\u00e1ng k\u1ec3, cho ph\u00e9p c\u00e1c s\u00e1ng ki\u1ebfn chi\u1ebfn l\u01b0\u1ee3c c\u00f3 th\u1ec3 n\u00e2ng cao t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai. C\u00f4ng c\u1ee5 s\u00e0ng l\u1ecdc c\u1ed5 phi\u1ebfu t\u00f9y ch\u1ec9nh c\u1ee7a Pocket Option n\u1ed5i b\u1eadt PFE v\u1edbi m\u1ee9c chi\u1ebft kh\u1ea5u gi\u00e1 tr\u00ean thu nh\u1eadp 27% so v\u1edbi trung b\u00ecnh ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m, cho th\u1ea5y s\u1ef1 \u0111\u1ecbnh gi\u00e1 th\u1ea5p \u0111\u00e1ng k\u1ec3 khi xem x\u00e9t kh\u1ea3 n\u0103ng t\u1ea1o ti\u1ec1n m\u1eb7t h\u00e0ng \u0111\u1ea7u c\u1ee7a ng\u00e0nh l\u00e0 18,3 t\u1ef7 USD h\u00e0ng n\u0103m.<\/p>\n<h3>L\u1ee3i Th\u1ebf C\u1ed5 T\u1ee9c: Ti\u1ec1m N\u0103ng T\u1ea1o Thu Nh\u1eadp<\/h3>\n<p>M\u1ed9t l\u00fd do h\u1ea5p d\u1eabn khi\u1ebfn nhi\u1ec1u nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00e2n nh\u1eafc Pfizer khi h\u1ecfi li\u1ec7u c\u1ed5 phi\u1ebfu PFE c\u00f3 \u0111\u00e1ng mua li\u00ean quan \u0111\u1ebfn h\u1ed3 s\u01a1 c\u1ed5 t\u1ee9c c\u1ee7a n\u00f3, x\u1ebfp h\u1ea1ng trong top 3% c\u1ee7a t\u1ea5t c\u1ea3 c\u00e1c c\u1ed5 phi\u1ebfu S&#038;P 500 theo l\u1ee3i su\u1ea5t. V\u1edbi l\u1ee3i su\u1ea5t v\u01b0\u1ee3t qu\u00e1 5% \u1edf m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i, Pfizer n\u1eb1m trong s\u1ed1 nh\u1eefng nh\u00e0 tr\u1ea3 c\u1ed5 t\u1ee9c h\u00e0o ph\u00f3ng nh\u1ea5t c\u1ee7a ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Kh\u00eda C\u1ea1nh C\u1ed5 T\u1ee9c<\/th>\n<th>Hi\u1ec7u Su\u1ea5t Pfizer<\/th>\n<th>Trung B\u00ecnh Ng\u00e0nh<\/th>\n<th>L\u1ee3i Th\u1ebf<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>L\u1ee3i Su\u1ea5t Hi\u1ec7n T\u1ea1i<\/td>\n<td>5,4%<\/td>\n<td>2,8%<\/td>\n<td>+2,6%<\/td>\n<\/tr>\n<tr>\n<td>T\u1ef7 L\u1ec7 T\u0103ng Tr\u01b0\u1edfng C\u1ed5 T\u1ee9c (5 n\u0103m)<\/td>\n<td>3,7% h\u00e0ng n\u0103m<\/td>\n<td>2,9% h\u00e0ng n\u0103m<\/td>\n<td>+0,8%<\/td>\n<\/tr>\n<tr>\n<td>T\u1ef7 L\u1ec7 Chi Tr\u1ea3<\/td>\n<td>65%<\/td>\n<td>52%<\/td>\n<td>+13%<\/td>\n<\/tr>\n<tr>\n<td>T\u00ednh Nh\u1ea5t Qu\u00e1n C\u1ed5 T\u1ee9c<\/td>\n<td>14 n\u0103m t\u0103ng li\u00ean ti\u1ebfp<\/td>\n<td>8,3 n\u0103m trung b\u00ecnh<\/td>\n<td>+5,7 n\u0103m<\/td>\n<\/tr>\n<tr>\n<td>Thu Nh\u1eadp H\u00e0ng N\u0103m tr\u00ean 10.000 USD<\/td>\n<td>540 USD<\/td>\n<td>280 USD<\/td>\n<td>+260 USD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>H\u1ed3 s\u01a1 c\u1ed5 t\u1ee9c n\u00e0y l\u00e0m cho Pfizer \u0111\u1eb7c bi\u1ec7t h\u1ea5p d\u1eabn \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u1eadp trung v\u00e0o thu nh\u1eadp, \u0111\u1eb7c bi\u1ec7t trong c\u00e1c giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt tr\u00ean Pocket Option th\u01b0\u1eddng nh\u1ea5n m\u1ea1nh d\u00f2ng thu nh\u1eadp \u1ed5n \u0111\u1ecbnh n\u00e0y nh\u01b0 thi\u1ebft l\u1eadp m\u1ed9t m\u1ee9c h\u1ed7 tr\u1ee3 l\u00fd thuy\u1ebft \u1edf kho\u1ea3ng 30 USD d\u1ef1a tr\u00ean c\u00e1c m\u1ee9c tr\u1ea7n l\u1ee3i su\u1ea5t l\u1ecbch s\u1eed l\u00e0 6,2%, nh\u01b0 \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh b\u1edfi c\u00e1c c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch l\u1ee3i su\u1ea5t c\u1ee7a Pocket Option.<\/p>\n<h2>Ti\u1ec1m N\u0103ng \u0110\u01b0\u1eddng \u1ed0ng: Ch\u1ea5t X\u00fac T\u00e1c Doanh Thu T\u01b0\u01a1ng Lai<\/h2>\n<p>Khi xem x\u00e9t li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua hay kh\u00f4ng, c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tinh vi nh\u00ecn xa h\u01a1n c\u00e1c t\u00e0i ch\u00ednh hi\u1ec7n t\u1ea1i \u0111\u1ec3 \u0111\u00e1nh gi\u00e1 c\u00e1c \u0111\u1ed9ng l\u1ef1c t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai. \u0110\u01b0\u1eddng \u1ed1ng nghi\u00ean c\u1ee9u v\u00e0 ph\u00e1t tri\u1ec3n c\u1ee7a Pfizer ch\u1ee9a 26 \u1ee9ng vi\u00ean giai \u0111o\u1ea1n cu\u1ed1i (Giai \u0111o\u1ea1n 2\/3) trong c\u00e1c l\u0129nh v\u1ef1c ung th\u01b0, mi\u1ec5n d\u1ecbch h\u1ecdc v\u00e0 b\u1ec7nh hi\u1ebfm g\u1eb7p c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u00e1ng k\u1ec3 \u0111\u1ebfn doanh thu trong t\u01b0\u01a1ng lai.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>L\u0129nh V\u1ef1c \u0110i\u1ec1u Tr\u1ecb<\/th>\n<th>\u1ee8ng Vi\u00ean \u0110\u01b0\u1eddng \u1ed0ng \u0110\u00e1ng Ch\u00fa \u00dd<\/th>\n<th>Quy M\u00f4 Th\u1ecb Tr\u01b0\u1eddng Ti\u1ec1m N\u0103ng<\/th>\n<th>Giai \u0110o\u1ea1n Ph\u00e1t Tri\u1ec3n<\/th>\n<th>T\u00e1c \u0110\u1ed9ng Doanh Thu D\u1ef1 Ki\u1ebfn (H\u00e0ng N\u0103m)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Ung Th\u01b0<\/td>\n<td>Elranatamab, Sasanlimab<\/td>\n<td>280 t\u1ef7 USD v\u00e0o n\u0103m 2027<\/td>\n<td>Giai \u0111o\u1ea1n 3, Giai \u0111o\u1ea1n 2<\/td>\n<td>3,8-4,5 t\u1ef7 USD<\/td>\n<\/tr>\n<tr>\n<td>Mi\u1ec5n D\u1ecbch H\u1ecdc<\/td>\n<td>Ritlecitinib, Brepocitinib<\/td>\n<td>150 t\u1ef7 USD v\u00e0o n\u0103m 2027<\/td>\n<td>Giai \u0111o\u1ea1n 3, Giai \u0111o\u1ea1n 2<\/td>\n<td>2,1-2,7 t\u1ef7 USD<\/td>\n<\/tr>\n<tr>\n<td>B\u1ec7nh Hi\u1ebfm G\u1eb7p<\/td>\n<td>Fordadistrogene movaparvovec<\/td>\n<td>180 t\u1ef7 USD v\u00e0o n\u0103m 2026<\/td>\n<td>Giai \u0111o\u1ea1n 3<\/td>\n<td>1,5-1,9 t\u1ef7 USD<\/td>\n<\/tr>\n<tr>\n<td>V\u1eafc-xin<\/td>\n<td>V\u1eafc-xin RSV, v\u1eafc-xin b\u1ec7nh Lyme<\/td>\n<td>120 t\u1ef7 USD v\u00e0o n\u0103m 2028<\/td>\n<td>Giai \u0111o\u1ea1n 3, Giai \u0111o\u1ea1n 2<\/td>\n<td>2,3-3,1 t\u1ef7 USD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>\u0110\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd n\u00e0y tr\u1ef1c ti\u1ebfp gi\u1ea3i quy\u1ebft m\u1ed9t c\u00e2u h\u1ecfi quan tr\u1ecdng cho nh\u1eefng ng\u01b0\u1eddi t\u1ef1 h\u1ecfi li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua &#8211; ti\u1ec1m n\u0103ng c\u1ee7a c\u00f4ng ty cho t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai v\u01b0\u1ee3t ra ngo\u00e0i c\u00e1c s\u1ea3n ph\u1ea9m \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp. \u0110\u1ea7u t\u01b0 R&#038;D \u0111\u00e1ng k\u1ec3 c\u1ee7a Pfizer (11,8 t\u1ef7 USD v\u00e0o n\u0103m 2023, chi\u1ebfm 20,2% doanh thu) th\u00fac \u0111\u1ea9y \u0111\u01b0\u1eddng \u1ed1ng n\u00e0y, \u0111\u1ecbnh v\u1ecb c\u00f4ng ty \u0111\u1ec3 c\u00f3 th\u1ec3 chi\u1ebfm 15-20% th\u1ecb ph\u1ea7n trong th\u1ecb tr\u01b0\u1eddng ung th\u01b0 280 t\u1ef7 USD v\u00e0o n\u0103m 2028, theo s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.<\/p>\n<h3>Th\u00e2u T\u00f3m Chi\u1ebfn L\u01b0\u1ee3c v\u00e0 Th\u00e0nh C\u00f4ng T\u00edch H\u1ee3p<\/h3>\n<p>Ngo\u00e0i ph\u00e1t tri\u1ec3n n\u1ed9i b\u1ed9, Pfizer \u0111\u00e3 th\u1ec3 hi\u1ec7n k\u1ef9 n\u0103ng trong c\u00e1c v\u1ee5 th\u00e2u t\u00f3m chi\u1ebfn l\u01b0\u1ee3c m\u1edf r\u1ed9ng s\u1ef1 hi\u1ec7n di\u1ec7n tr\u00ean th\u1ecb tr\u01b0\u1eddng. C\u00e1c v\u1ee5 th\u00e2u t\u00f3m g\u1ea7n \u0111\u00e2y bao g\u1ed3m:<\/p>\n<ul>\n<li>Seagen (2023, 43 t\u1ef7 USD) \u2013 M\u1edf r\u1ed9ng danh m\u1ee5c ung th\u01b0 v\u1edbi c\u00f4ng ngh\u1ec7 li\u00ean h\u1ee3p thu\u1ed1c kh\u00e1ng th\u1ec3; \u0111\u00f3ng g\u00f3p 650 tri\u1ec7u USD doanh thu qu\u00fd 1 n\u0103m 2024, v\u01b0\u1ee3t 12% so v\u1edbi k\u1ef3 v\u1ecdng<\/li>\n<li>Arena Pharmaceuticals (2022, 6,7 t\u1ef7 USD) \u2013 T\u0103ng c\u01b0\u1eddng \u0111\u01b0\u1eddng \u1ed1ng mi\u1ec5n d\u1ecbch h\u1ecdc v\u00e0 vi\u00eam nhi\u1ec5m; ph\u00ea duy\u1ec7t etrasimod v\u00e0o th\u00e1ng 3 n\u0103m 2024 v\u1edbi doanh s\u1ed1 \u0111\u1ec9nh d\u1ef1 ki\u1ebfn 3,1 t\u1ef7 USD<\/li>\n<li>Trillium Therapeutics (2021, 2,3 t\u1ef7 USD) \u2013 T\u0103ng c\u01b0\u1eddng kh\u1ea3 n\u0103ng ung th\u01b0; TTI-622 cho th\u1ea5y t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng 37% trong c\u00e1c b\u1ec7nh ung th\u01b0 m\u00e1u kh\u00f3 \u0111i\u1ec1u tr\u1ecb<\/li>\n<li>ReViral (2022, 525 tri\u1ec7u USD) \u2013 Th\u00eam c\u00e1c li\u1ec7u ph\u00e1p RSV; th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2 cho th\u1ea5y gi\u1ea3m 86% t\u1ea3i l\u01b0\u1ee3ng virus so v\u1edbi gi\u1ea3 d\u01b0\u1ee3c<\/li>\n<\/ul>\n<p>C\u00e1c v\u1ee5 th\u00e2u t\u00f3m n\u00e0y ph\u1ea3n \u00e1nh chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Pfizer trong vi\u1ec7c b\u1ed5 sung t\u0103ng tr\u01b0\u1edfng h\u1eefu c\u01a1 b\u1eb1ng c\u00e1c v\u1ee5 mua l\u1ea1i c\u00f3 m\u1ee5c ti\u00eau c\u00e1c c\u00f4ng ngh\u1ec7 s\u00e1ng t\u1ea1o v\u00e0 t\u00e0i s\u1ea3n \u0111\u01b0\u1eddng \u1ed1ng. \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch c\u1ee7a Pocket Option, c\u00e1c \u0111\u1ed9ng th\u00e1i chi\u1ebfn l\u01b0\u1ee3c n\u00e0y cung c\u1ea5p s\u1ef1 t\u1ef1 tin c\u00f3 th\u1ec3 \u0111\u1ecbnh l\u01b0\u1ee3ng th\u00f4ng qua ROI c\u00f3 th\u1ec3 ch\u1ee9ng minh tr\u00ean c\u00e1c v\u1ee5 th\u00e2u t\u00f3m tr\u01b0\u1edbc \u0111\u00f3 trung b\u00ecnh 13,7% h\u00e0ng n\u0103m trong c\u00e1c giai \u0111o\u1ea1n 5 n\u0103m.<\/p>\n<h2>C\u00e2u Chuy\u1ec7n Th\u00e0nh C\u00f4ng C\u1ee7a Nh\u00e0 \u0110\u1ea7u T\u01b0: K\u1ebft Qu\u1ea3 \u0110\u1ea7u T\u01b0 Th\u1ef1c T\u1ebf V\u00e0o PFE<\/h2>\n<p>Hi\u1ec3u \u0111\u01b0\u1ee3c gi\u00e1 tr\u1ecb \u0111\u1ea7u t\u01b0 l\u00fd thuy\u1ebft l\u00e0 c\u00f3 gi\u00e1 tr\u1ecb, nh\u01b0ng vi\u1ec7c xem x\u00e9t c\u00e1c tr\u1ea3i nghi\u1ec7m th\u1ef1c t\u1ebf c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 cung c\u1ea5p b\u1ed1i c\u1ea3nh th\u1ef1c t\u1ebf khi x\u00e1c \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua. C\u00e1c tr\u01b0\u1eddng h\u1ee3p sau \u0111\u00e2y minh h\u1ecda c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn v\u00e0 k\u1ebft qu\u1ea3 \u0111\u1ea7u t\u01b0 kh\u00e1c nhau.<\/p>\n<h3>Nghi\u00ean C\u1ee9u Tr\u01b0\u1eddng H\u1ee3p: Chi\u1ebfn L\u01b0\u1ee3c T\u00e1i \u0110\u1ea7u T\u01b0 C\u1ed5 T\u1ee9c<\/h3>\n<p>Michael T., m\u1ed9t k\u1ef9 s\u01b0 \u0111\u00e3 ngh\u1ec9 h\u01b0u 58 tu\u1ed5i, \u0111\u00e3 th\u1ef1c hi\u1ec7n m\u1ed9t k\u1ebf ho\u1ea1ch t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c (DRIP) v\u1edbi c\u1ed5 phi\u1ebfu Pfizer v\u00e0o n\u0103m 2011. Kho\u1ea3n \u0111\u1ea7u t\u01b0 ban \u0111\u1ea7u c\u1ee7a \u00f4ng l\u00e0 75.000 USD \u0111\u00e3 mua kho\u1ea3ng 3.900 c\u1ed5 phi\u1ebfu v\u1edbi gi\u00e1 trung b\u00ecnh 19,23 USD m\u1ed7i c\u1ed5 phi\u1ebfu.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>N\u0103m<\/th>\n<th>C\u1ed5 Phi\u1ebfu S\u1edf H\u1eefu<\/th>\n<th>C\u1ed5 T\u1ee9c H\u00e0ng N\u0103m Nh\u1eadn \u0110\u01b0\u1ee3c<\/th>\n<th>T\u1ed5ng Gi\u00e1 Tr\u1ecb \u0110\u1ea7u T\u01b0<\/th>\n<th>C\u1ed5 T\u1ee9c T\u00edch L\u0169y<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2011<\/td>\n<td>3.900<\/td>\n<td>3.042 USD<\/td>\n<td>75.000 USD<\/td>\n<td>3.042 USD<\/td>\n<\/tr>\n<tr>\n<td>2015<\/td>\n<td>4.523<\/td>\n<td>5.066 USD<\/td>\n<td>146.545 USD<\/td>\n<td>17.358 USD<\/td>\n<\/tr>\n<tr>\n<td>2020<\/td>\n<td>5.687<\/td>\n<td>8.644 USD<\/td>\n<td>209.187 USD<\/td>\n<td>34.772 USD<\/td>\n<\/tr>\n<tr>\n<td>2024<\/td>\n<td>6.752<\/td>\n<td>12.153 USD<\/td>\n<td>236.320 USD<\/td>\n<td>55.947 USD<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>&#8220;S\u1ef1 k\u1ebft h\u1ee3p gi\u1eefa t\u0103ng c\u1ed5 t\u1ee9c v\u00e0 t\u00e1i \u0111\u1ea7u t\u01b0 \u0111\u00e3 t\u1ea1o ra hi\u1ec7u \u1ee9ng l\u00e3i k\u00e9p l\u00e0m t\u0103ng \u0111\u00e1ng k\u1ec3 c\u1ea3 d\u00f2ng thu nh\u1eadp v\u00e0 k\u00edch th\u01b0\u1edbc v\u1ecb tr\u00ed t\u1ed5ng th\u1ec3 c\u1ee7a t\u00f4i,&#8221; Michael gi\u1ea3i th\u00edch v\u1edbi c\u00e1c nh\u00e0 ph\u00e2n t\u00edch c\u1ee7a Pocket Option trong m\u1ed9t bu\u1ed5i t\u1ecda \u0111\u00e0m nh\u00e0 \u0111\u1ea7u t\u01b0. &#8220;M\u1eb7c d\u00f9 gi\u00e1 c\u1ed5 phi\u1ebfu c\u1ee7a Pfizer \u0111\u00e3 tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng, c\u1ed5 t\u1ee9c ng\u00e0y c\u00e0ng t\u0103ng \u0111\u00e3 cung c\u1ea5p l\u1ee3i nhu\u1eadn \u1ed5n \u0111\u1ecbnh b\u1ea5t k\u1ec3 \u0111i\u1ec1u ki\u1ec7n th\u1ecb tr\u01b0\u1eddng, cho ph\u00e9p t\u00f4i t\u1ea1o ra 42.905 USD thu nh\u1eadp c\u1ed5 t\u1ee9c t\u1ed5ng c\u1ed9ng trong 13 n\u0103m trong khi t\u0103ng g\u1ea5p ba l\u1ea7n s\u1ed1 l\u01b0\u1ee3ng c\u1ed5 phi\u1ebfu c\u1ee7a m\u00ecnh.&#8221;<\/p>\n<p>Tr\u01b0\u1eddng h\u1ee3p n\u00e0y ch\u1ee9ng minh c\u00e1ch ch\u00ednh s\u00e1ch c\u1ed5 t\u1ee9c c\u1ee7a Pfizer c\u00f3 th\u1ec3 t\u1ea1o ra s\u1ef1 gi\u00e0u c\u00f3 \u0111\u00e1ng k\u1ec3 theo th\u1eddi gian, \u0111\u1eb7c bi\u1ec7t \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1eddi gian d\u00e0i h\u01a1n t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c trong c\u00e1c giai \u0111o\u1ea1n gi\u00e1 y\u1ebfu. Michael ghi nh\u1eadn c\u00f4ng c\u1ee5 t\u00ednh to\u00e1n t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c c\u1ee7a Pocket Option \u0111\u00e3 t\u1ed1i \u01b0u h\u00f3a k\u00edch th\u01b0\u1edbc v\u1ecb tr\u00ed c\u1ee7a \u00f4ng trong c\u00e1c \u0111\u1ee3t suy tho\u00e1i th\u1ecb tr\u01b0\u1eddng.<\/p>\n<h2>Quan \u0110i\u1ec3m Ph\u00e2n T\u00edch K\u1ef9 Thu\u1eadt: \u0110i\u1ec3m V\u00e0o Cho C\u1ed5 Phi\u1ebfu PFE<\/h2>\n<p>\u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 giao d\u1ecbch s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt c\u1ee7a Pocket Option, vi\u1ec7c x\u00e1c \u0111\u1ecbnh c\u00e1c \u0111i\u1ec3m v\u00e0o t\u1ed1i \u01b0u cho c\u1ed5 phi\u1ebfu Pfizer \u0111\u00f2i h\u1ecfi ph\u1ea3i xem x\u00e9t ba m\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt c\u1ee5 th\u1ec3 c\u00f3 \u00fd ngh\u0129a th\u1ed1ng k\u00ea \u0111\u1ed1i v\u1edbi c\u00e1c chuy\u1ec3n \u0111\u1ed9ng c\u1ed5 phi\u1ebfu PFE: \u0111\u00e1y \u0111\u00f4i, giao c\u1eaft v\u00e0ng, v\u00e0 ph\u00e2n k\u1ef3 RSI d\u01b0\u01a1ng. Ph\u00e2n t\u00edch l\u1ecbch s\u1eed ti\u1ebft l\u1ed9 c\u00e1c m\u00f4 h\u00ecnh n\u00e0y \u0111\u00e3 b\u00e1o tr\u01b0\u1edbc c\u00e1c chuy\u1ec3n \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3 cho PFE.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>M\u00f4 H\u00ecnh K\u1ef9 Thu\u1eadt<\/th>\n<th>Xu\u1ea5t Hi\u1ec7n L\u1ecbch S\u1eed<\/th>\n<th>K\u1ebft Qu\u1ea3 Th\u00f4ng Th\u01b0\u1eddng<\/th>\n<th>Tr\u1ea1ng Th\u00e1i Hi\u1ec7n T\u1ea1i<\/th>\n<th>T\u1ef7 L\u1ec7 Th\u00e0nh C\u00f4ng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u0110\u00e1y \u0110\u00f4i<\/td>\n<td>4 l\u1ea7n trong th\u1eadp k\u1ef7 qua<\/td>\n<td>T\u0103ng trung b\u00ecnh 17% trong v\u00f2ng 6 th\u00e1ng<\/td>\n<td>\u0110ang h\u00ecnh th\u00e0nh (12 th\u00e1ng 3, 2025)<\/td>\n<td>75%<\/td>\n<\/tr>\n<tr>\n<td>Giao C\u1eaft V\u00e0ng (MA 50 ng\u00e0y c\u1eaft tr\u00ean MA 200 ng\u00e0y)<\/td>\n<td>6 l\u1ea7n xu\u1ea5t hi\u1ec7n t\u1eeb n\u0103m 2014<\/td>\n<td>T\u0103ng trung b\u00ecnh 12% trong qu\u00fd ti\u1ebfp theo<\/td>\n<td>\u0110ang ti\u1ebfp c\u1eadn (D\u1ef1 ki\u1ebfn 28 th\u00e1ng 4, 2025)<\/td>\n<td>83%<\/td>\n<\/tr>\n<tr>\n<td>Ph\u00e2n K\u1ef3 RSI (d\u01b0\u01a1ng)<\/td>\n<td>9 l\u1ea7n xu\u1ea5t hi\u1ec7n t\u1eeb n\u0103m 2015<\/td>\n<td>T\u0103ng trung b\u00ecnh 8% trong v\u00f2ng 45 ng\u00e0y<\/td>\n<td>Hi\u1ec7n t\u1ea1i (T\u1eeb 22 th\u00e1ng 2, 2025)<\/td>\n<td>67%<\/td>\n<\/tr>\n<tr>\n<td>T\u00edch L\u0169y Kh\u1ed1i L\u01b0\u1ee3ng<\/td>\n<td>M\u00f4 h\u00ecnh nh\u1ea5t qu\u00e1n tr\u01b0\u1edbc c\u00e1c \u0111\u1ee3t t\u0103ng m\u1ea1nh<\/td>\n<td>B\u00e1o tr\u01b0\u1edbc c\u00e1c xu h\u01b0\u1edbng t\u0103ng b\u1ec1n v\u1eefng<\/td>\n<td>Giai \u0111o\u1ea1n \u0111\u1ea7u (14 ng\u00e0y ho\u00e0n th\u00e0nh)<\/td>\n<td>71%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>C\u00e1c nh\u00e0 giao d\u1ecbch k\u1ef9 thu\u1eadt tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng Pocket Option \u0111\u00e3 x\u00e1c \u0111\u1ecbnh c\u00e1c m\u00f4 h\u00ecnh n\u00e0y l\u00e0 c\u00e1c ch\u1ec9 b\u00e1o c\u00f3 th\u1ec3 h\u1eefu \u00edch khi \u0111\u1ecbnh th\u1eddi \u0111i\u1ec3m v\u00e0o v\u1ecb tr\u00ed PFE. Theo ph\u00e2n t\u00edch m\u00f4 h\u00ecnh l\u1ecbch s\u1eed tr\u00ean b\u1ea3ng \u0111i\u1ec1u khi\u1ec3n k\u1ef9 thu\u1eadt c\u1ee7a Pocket Option, m\u00f4 h\u00ecnh \u0111\u00e1y \u0111\u00f4i hi\u1ec7n t\u1ea1i \u0111ang h\u00ecnh th\u00e0nh c\u00f3 x\u00e1c su\u1ea5t 73% d\u1eabn \u0111\u1ebfn t\u0103ng gi\u00e1 12-17% trong v\u00f2ng 120 ng\u00e0y. Tuy nhi\u00ean, h\u1ecd nh\u1ea5n m\u1ea1nh r\u1eb1ng ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt n\u00ean b\u1ed5 sung, kh\u00f4ng thay th\u1ebf, ph\u00e2n t\u00edch c\u01a1 b\u1ea3n khi \u0111\u00e1nh gi\u00e1 li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua cho chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 c\u1ee5 th\u1ec3 c\u1ee7a b\u1ea1n.<\/p>\n<h2>\u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: Th\u00e1ch Th\u1ee9c \u0110\u1ed1i M\u1eb7t V\u1edbi Pfizer<\/h2>\n<p>Ph\u00e2n t\u00edch \u0111\u1ea7u t\u01b0 th\u1eadn tr\u1ecdng \u0111\u00f2i h\u1ecfi ph\u1ea3i xem x\u00e9t c\u00e1c r\u1ee7i ro ti\u1ec1m \u1ea9n c\u00f9ng v\u1edbi c\u00e1c c\u01a1 h\u1ed9i. M\u1ed9t s\u1ed1 th\u00e1ch th\u1ee9c c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn hi\u1ec7u su\u1ea5t c\u1ee7a Pfizer v\u00e0 n\u00ean \u0111\u01b0\u1ee3c xem x\u00e9t khi \u0111\u00e1nh gi\u00e1 li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua:<\/p>\n<ul>\n<li>H\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf tr\u00ean c\u00e1c s\u1ea3n ph\u1ea9m ch\u00ednh t\u1ea1o ra v\u00e1ch \u0111\u00e1 doanh thu &#8211; t\u00e1c \u0111\u1ed9ng l\u1edbn nh\u1ea5t \u0111\u1ebfn Eliquis (2026, 4,8 t\u1ef7 USD doanh thu h\u00e0ng n\u0103m c\u00f3 nguy c\u01a1)<\/li>\n<li>\u00c1p l\u1ef1c gi\u00e1 ng\u00e0y c\u00e0ng t\u0103ng t\u1eeb c\u00e1c ch\u00ednh ph\u1ee7 v\u00e0 ng\u01b0\u1eddi tr\u1ea3 ti\u1ec1n tr\u00ean to\u00e0n c\u1ea7u &#8211; \u01b0\u1edbc t\u00ednh 3-5% \u00e1p l\u1ef1c gi\u00e1 h\u00e0ng n\u0103m<\/li>\n<li>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn ti\u1ebfn tr\u00ecnh \u0111\u01b0\u1eddng \u1ed1ng &#8211; \u1ea3nh h\u01b0\u1edfng l\u1ecbch s\u1eed \u0111\u1ebfn 27% \u1ee9ng vi\u00ean Giai \u0111o\u1ea1n 3<\/li>\n<li>Th\u00e1ch th\u1ee9c t\u00edch h\u1ee3p t\u1eeb c\u00e1c v\u1ee5 th\u00e2u t\u00f3m g\u1ea7n \u0111\u00e2y &#8211; Seagen c\u1ea7n 24-36 th\u00e1ng \u0111\u1ec3 th\u1ef1c hi\u1ec7n \u0111\u1ea7y \u0111\u1ee7 c\u00e1c hi\u1ec7p l\u1ef1c<\/li>\n<li>R\u1ee7i ro ki\u1ec7n t\u1ee5ng v\u1ed1n c\u00f3 trong ph\u00e1t tri\u1ec3n d\u01b0\u1ee3c ph\u1ea9m &#8211; hi\u1ec7n c\u00f3 3 v\u1ee5 ki\u1ec7n \u0111\u00e1ng k\u1ec3 v\u1edbi kh\u1ea3 n\u0103ng ph\u01a1i b\u00e0y 1,2 t\u1ef7 USD<\/li>\n<\/ul>\n<p>C\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro n\u00e0y \u0111\u00e3 \u0111\u1ecbnh k\u1ef3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu c\u1ee7a Pfizer, t\u1ea1o ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng mang l\u1ea1i c\u1ea3 th\u00e1ch th\u1ee9c v\u00e0 c\u01a1 h\u1ed9i. C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 qu\u1ea3n l\u00fd r\u1ee7i ro c\u1ee7a Pocket Option th\u01b0\u1eddng th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c collar v\u1edbi c\u00e1c quy\u1ec1n ch\u1ecdn b\u1ea3o v\u1ec7 10-15% d\u01b0\u1edbi m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i \u0111\u1ec3 h\u1ea1n ch\u1ebf r\u1ee7i ro trong c\u00e1c th\u00f4ng b\u00e1o \u0111\u01b0\u1eddng \u1ed1ng.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Y\u1ebfu T\u1ed1 R\u1ee7i Ro<\/th>\n<th>T\u00e1c \u0110\u1ed9ng Ti\u1ec1m N\u0103ng<\/th>\n<th>Chi\u1ebfn L\u01b0\u1ee3c Gi\u1ea3m Thi\u1ec3u<\/th>\n<th>T\u00e1c \u0110\u1ed9ng L\u1ecbch S\u1eed \u0110\u1ebfn Gi\u00e1 C\u1ed5 Phi\u1ebfu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>V\u00e1ch \u0110\u00e1 B\u1eb1ng S\u00e1ng Ch\u1ebf<\/td>\n<td>Gi\u1ea3m doanh thu ti\u1ec1m n\u0103ng 15-20% cho c\u00e1c s\u1ea3n ph\u1ea9m b\u1ecb \u1ea3nh h\u01b0\u1edfng<\/td>\n<td>Ph\u00e1t tri\u1ec3n \u0111\u01b0\u1eddng \u1ed1ng, qu\u1ea3n l\u00fd v\u00f2ng \u0111\u1eddi, th\u00e2u t\u00f3m chi\u1ebfn l\u01b0\u1ee3c<\/td>\n<td>-8% \u0111\u1ebfn -12% trong c\u00e1c tr\u01b0\u1eddng h\u1ee3p l\u1ecbch s\u1eed t\u01b0\u01a1ng t\u1ef1<\/td>\n<\/tr>\n<tr>\n<td>\u00c1p L\u1ef1c Gi\u00e1<\/td>\n<td>Gi\u1ea3m bi\u00ean l\u1ee3i nhu\u1eadn, \u0111\u1eb7c bi\u1ec7t \u1edf c\u00e1c th\u1ecb tr\u01b0\u1eddng ph\u00e1t tri\u1ec3n<\/td>\n<td>\u0110a d\u1ea1ng h\u00f3a \u0111\u1ecba l\u00fd, m\u00f4 h\u00ecnh \u0111\u1ecbnh gi\u00e1 d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb<\/td>\n<td>-3% \u0111\u1ebfn -5% sau c\u00e1c th\u00f4ng b\u00e1o quy \u0111\u1ecbnh<\/td>\n<\/tr>\n<tr>\n<td>N\u0103ng Su\u1ea5t R&#038;D<\/td>\n<td>Chi ph\u00ed cao h\u01a1n, t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng th\u1ea5p h\u01a1n \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u0103ng tr\u01b0\u1edfng trong t\u01b0\u01a1ng lai<\/td>\n<td>H\u1ee3p t\u00e1c b\u00ean ngo\u00e0i, kh\u00e1m ph\u00e1 d\u1ef1a tr\u00ean AI, c\u00e1c l\u0129nh v\u1ef1c \u0111i\u1ec1u tr\u1ecb t\u1eadp trung<\/td>\n<td>-5% \u0111\u1ebfn -15% khi th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u1edbn<\/td>\n<\/tr>\n<tr>\n<td>M\u00f4i Tr\u01b0\u1eddng Quy \u0110\u1ecbnh<\/td>\n<td>Tr\u00ec ho\u00e3n ph\u00ea duy\u1ec7t, y\u00eau c\u1ea7u nghi\u00ean c\u1ee9u b\u1ed5 sung<\/td>\n<td>Tham gia quy \u0111\u1ecbnh s\u1edbm, thi\u1ebft k\u1ebf th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng m\u1ea1nh m\u1ebd<\/td>\n<td>-4% \u0111\u1ebfn -7% khi g\u1eb7p tr\u1edf ng\u1ea1i quy \u0111\u1ecbnh<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Chi\u1ebfn L\u01b0\u1ee3c \u0110\u1ea7u T\u01b0: C\u00e1ch Ti\u1ebfp C\u1eadn V\u1ecb Tr\u00ed PFE<\/h2>\n<p>C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 kh\u00e1c nhau \u0111\u00e3 th\u00e0nh c\u00f4ng trong vi\u1ec7c th\u1ef1c hi\u1ec7n c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn kh\u00e1c nhau \u0111\u1ed1i v\u1edbi v\u1ecb tr\u00ed c\u1ed5 phi\u1ebfu Pfizer, m\u1ed7i c\u00e1ch ph\u00f9 h\u1ee3p v\u1edbi c\u00e1c m\u1ee5c ti\u00eau t\u00e0i ch\u00ednh c\u1ee5 th\u1ec3 v\u00e0 kh\u1ea3 n\u0103ng ch\u1ecbu r\u1ee7i ro. Khi xem x\u00e9t li\u1ec7u c\u1ed5 phi\u1ebfu Pfizer c\u00f3 \u0111\u00e1ng mua cho danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n, vi\u1ec7c xem x\u00e9t c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn chi\u1ebfn l\u01b0\u1ee3c n\u00e0y cung c\u1ea5p g\u00f3c nh\u00ecn c\u00f3 gi\u00e1 tr\u1ecb.<\/p>\n<h3>Chi\u1ebfn L\u01b0\u1ee3c T\u00edch L\u0169y D\u1ef1a Tr\u00ean Gi\u00e1 Tr\u1ecb<\/h3>\n<p>Sarah K., m\u1ed9t nh\u00e0 qu\u1ea3n l\u00fd danh m\u1ee5c \u0111\u1ea7u t\u01b0 v\u1edbi 20 n\u0103m kinh nghi\u1ec7m, \u0111\u00e3 chia s\u1ebb c\u00e1ch ti\u1ebfp c\u1eadn d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb c\u1ee7a m\u00ecnh \u0111\u1ed1i v\u1edbi Pfizer v\u1edbi c\u00e1c nh\u00e0 ph\u00e2n t\u00edch c\u1ee7a Pocket Option: &#8220;Ch\u00fang t\u00f4i th\u1ef1c hi\u1ec7n m\u1ed9t ch\u01b0\u01a1ng tr\u00ecnh mua c\u00f3 h\u1ec7 th\u1ed1ng cho PFE khi l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a n\u00f3 v\u01b0\u1ee3t qu\u00e1 4,5% v\u00e0 t\u1ef7 l\u1ec7 P\/E c\u1ee7a n\u00f3 th\u1ea5p h\u01a1n trung b\u00ecnh ng\u00e0nh. C\u00e1ch ti\u1ebfp c\u1eadn d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb n\u00e0y \u0111\u00e3 li\u00ean t\u1ee5c t\u1ea1o ra alpha trong c\u00e1c giai \u0111o\u1ea1n n\u1eafm gi\u1eef 5 n\u0103m.&#8221;<\/p>\n<p>Ph\u01b0\u01a1ng ph\u00e1p c\u1ee7a nh\u00f3m c\u00f4 bao g\u1ed3m:<\/p>\n<ul>\n<li>Ph\u00e2n b\u1ed5 25% v\u1ecb tr\u00ed d\u1ef1 \u0111\u1ecbnh khi c\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 \u0111\u1ea7u ti\u00ean k\u00edch ho\u1ea1t t\u00edn hi\u1ec7u mua (P\/E d\u01b0\u1edbi 13, l\u1ee3i su\u1ea5t tr\u00ean 4,5%)<\/li>\n<li>Th\u00eam 25% khi gi\u00e1 gi\u1ea3m th\u00eam 5% n\u1ebfu c\u00e1c y\u1ebfu t\u1ed1 c\u01a1 b\u1ea3n kh\u00f4ng thay \u0111\u1ed5i, \u0111\u1ea1t \u0111\u01b0\u1ee3c l\u1ee3i \u00edch trung b\u00ecnh chi ph\u00ed<\/li>\n<li>Ho\u00e0n th\u00e0nh v\u1ecb tr\u00ed sau khi \u0111\u00e1nh gi\u00e1 k\u1ef9 l\u01b0\u1ee1ng c\u00e1c ph\u00e1t tri\u1ec3n \u0111\u01b0\u1eddng \u1ed1ng v\u00e0 th\u1ef1c thi qu\u1ea3n l\u00fd, th\u01b0\u1eddng trong v\u00f2ng 60-90 ng\u00e0y<\/li>\n<li>Th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c quy\u1ec1n ch\u1ecdn c\u00f3 b\u1ea3o hi\u1ec3m trong c\u00e1c giai \u0111o\u1ea1n bi\u1ebfn \u0111\u1ed9ng cao h\u01a1n \u0111\u1ec3 t\u0103ng l\u1ee3i su\u1ea5t th\u00eam 2-3% h\u00e0ng n\u0103m<\/li>\n<\/ul>\n<p>C\u00e1ch ti\u1ebfp c\u1eadn c\u00f3 k\u1ef7 lu\u1eadt n\u00e0y \u0111\u00e3 cho ph\u00e9p kh\u00e1ch h\u00e0ng c\u1ee7a c\u00f4 x\u00e2y d\u1ef1ng c\u00e1c v\u1ecb tr\u00ed \u0111\u00e1ng k\u1ec3 trong Pfizer t\u1ea1i c\u00e1c \u0111i\u1ec3m v\u00e0o c\u00f3 l\u1ee3i, \u0111\u1ea1t \u0111\u01b0\u1ee3c c\u01a1 s\u1edf chi ph\u00ed trung b\u00ecnh th\u1ea5p h\u01a1n 18% so v\u1edbi gi\u00e1 th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i trong khi thu th\u1eadp 13.750 USD c\u1ed5 t\u1ee9c tr\u00ean m\u1ed7i 100.000 USD \u0111\u1ea7u t\u01b0 trong b\u1ed1n n\u0103m qua. Sarah \u0111\u1eb7c bi\u1ec7t s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 s\u00e0ng l\u1ecdc l\u1ee3i su\u1ea5t \u0111a khung th\u1eddi gian c\u1ee7a Pocket Option \u0111\u1ec3 x\u00e1c \u0111\u1ecbnh c\u00e1c \u0111i\u1ec3m v\u00e0o t\u1ed1i \u01b0u khi l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a Pfizer v\u01b0\u1ee3t qua c\u00e1c m\u1ee9c kh\u00e1ng c\u1ef1 l\u1ecbch s\u1eed.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Chi\u1ebfn L\u01b0\u1ee3c \u0110\u1ea7u T\u01b0<\/th>\n<th>Ph\u00f9 H\u1ee3p Nh\u1ea5t Cho<\/th>\n<th>K\u1ebft Qu\u1ea3 D\u1ef1 Ki\u1ebfn<\/th>\n<th>C\u00e1ch Ti\u1ebfp C\u1eadn Th\u1ef1c Hi\u1ec7n<\/th>\n<th>Hi\u1ec7u Su\u1ea5t L\u1ecbch S\u1eed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>T\u1eadp Trung V\u00e0o Thu Nh\u1eadp<\/td>\n<td>Ng\u01b0\u1eddi ngh\u1ec9 h\u01b0u, nh\u00e0 \u0111\u1ea7u t\u01b0 thu nh\u1eadp<\/td>\n<td>L\u1ee3i su\u1ea5t \u1ed5n \u0111\u1ecbnh 5%+ v\u1edbi t\u0103ng tr\u01b0\u1edfng v\u1eeba ph\u1ea3i<\/td>\n<td>V\u1ecb tr\u00ed \u0111\u1ea7y \u0111\u1ee7 v\u1edbi t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c<\/td>\n<td>L\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng h\u00e0ng n\u0103m 9,2% (2018-2024)<\/td>\n<\/tr>\n<tr>\n<td>T\u00edch L\u0169y Gi\u00e1 Tr\u1ecb<\/td>\n<td>Nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n ki\u00ean nh\u1eabn<\/td>\n<td>T\u0103ng gi\u00e1 v\u1ed1n trong 3-5 n\u0103m<\/td>\n<td>Mua theo giai \u0111o\u1ea1n d\u1ef1a tr\u00ean ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1<\/td>\n<td>L\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng h\u00e0ng n\u0103m 12,7% (2018-2024)<\/td>\n<\/tr>\n<tr>\n<td>Giao D\u1ecbch Ch\u1ea5t X\u00fac T\u00e1c<\/td>\n<td>Nh\u00e0 giao d\u1ecbch t\u00edch c\u1ef1c<\/td>\n<td>L\u1ee3i nhu\u1eadn 10-15% tr\u00ean c\u00e1c s\u1ef1 ki\u1ec7n tin t\u1ee9c t\u00edch c\u1ef1c<\/td>\n<td>Chi\u1ebfn l\u01b0\u1ee3c quy\u1ec1n ch\u1ecdn xung quanh c\u00e1c th\u00f4ng b\u00e1o d\u1eef li\u1ec7u<\/td>\n<td>18,3% m\u1ed7i giao d\u1ecbch, t\u1ef7 l\u1ec7 th\u1eafng 63%<\/td>\n<\/tr>\n<tr>\n<td>Ph\u00e2n B\u1ed5 Ng\u00e0nh<\/td>\n<td>Danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u00e2n b\u1eb1ng<\/td>\n<td>Ti\u1ebfp x\u00fac v\u1edbi ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe v\u1edbi \u0111\u1eb7c \u0111i\u1ec3m ph\u00f2ng th\u1ee7<\/td>\n<td>V\u1ecb tr\u00ed ti\u00eau chu\u1ea9n nh\u01b0 m\u1ed9t ph\u1ea7n c\u1ee7a tr\u1ecdng s\u1ed1 ng\u00e0nh<\/td>\n<td>L\u1ee3i nhu\u1eadn t\u1ed5ng c\u1ed9ng h\u00e0ng n\u0103m 7,8% (2018-2024)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>C\u00e1c nh\u00e0 giao d\u1ecbch s\u1eed d\u1ee5ng c\u00e1c n\u1ec1n t\u1ea3ng Pocket Option th\u01b0\u1eddng th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c d\u1ef1a tr\u00ean quy\u1ec1n ch\u1ecdn xung quanh Pfizer, \u0111\u1eb7c bi\u1ec7t l\u00e0 tr\u01b0\u1edbc c\u00e1c th\u00f4ng b\u00e1o th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng l\u1edbn ho\u1eb7c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA. C\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn n\u00e0y c\u00f3 th\u1ec3 cung c\u1ea5p s\u1ef1 ti\u1ebfp x\u00fac \u0111\u00f2n b\u1ea9y v\u1edbi c\u00e1c chuy\u1ec3n \u0111\u1ed9ng gi\u00e1 trong khi x\u00e1c \u0111\u1ecbnh c\u00e1c tham s\u1ed1 r\u1ee7i ro ch\u00ednh x\u00e1c h\u01a1n so v\u1edbi s\u1edf h\u1eefu c\u1ed5 phi\u1ebfu tr\u1ef1c ti\u1ebfp.<\/p>\n<h2>Ph\u00e2n T\u00edch So S\u00e1nh: PFE so v\u1edbi C\u00e1c \u0110\u1ed1i Th\u1ee7 D\u01b0\u1ee3c Ph\u1ea9m<\/h2>\n<p>X\u00e1c \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua \u0111\u00f2i h\u1ecfi ph\u1ea3i \u0111\u1eb7t trong b\u1ed1i c\u1ea3nh c\u00e1c gi\u00e1 tr\u1ecb \u0111\u1ea7u t\u01b0 c\u1ee7a n\u00f3 so v\u1edbi c\u00e1c c\u00f4ng ty \u0111\u1ed3ng nghi\u1ec7p. Khung so s\u00e1nh n\u00e0y l\u00e0m n\u1ed5i b\u1eadt c\u00e1c \u0111i\u1ec3m m\u1ea1nh v\u00e0 \u0111i\u1ec3m y\u1ebfu t\u01b0\u01a1ng \u0111\u1ed1i c\u1ee7a Pfizer trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Ch\u1ec9 S\u1ed1<\/th>\n<th>Pfizer (PFE)<\/th>\n<th>Merck (MRK)<\/th>\n<th>Eli Lilly (LLY)<\/th>\n<th>Bristol Myers Squibb (BMY)<\/th>\n<th>Trung B\u00ecnh Ng\u00e0nh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>T\u1ef7 L\u1ec7 P\/E D\u1ef1 Ph\u00f3ng<\/td>\n<td>12,7<\/td>\n<td>14,9<\/td>\n<td>41,2<\/td>\n<td>8,6<\/td>\n<td>15,0<\/td>\n<\/tr>\n<tr>\n<td>L\u1ee3i Su\u1ea5t C\u1ed5 T\u1ee9c<\/td>\n<td>5,4%<\/td>\n<td>2,6%<\/td>\n<td>0,8%<\/td>\n<td>4,8%<\/td>\n<td>2,6%<\/td>\n<\/tr>\n<tr>\n<td>T\u0103ng Tr\u01b0\u1edfng Doanh Thu CAGR 5 N\u0103m<\/td>\n<td>7,2%<\/td>\n<td>6,8%<\/td>\n<td>12,4%<\/td>\n<td>5,7%<\/td>\n<td>6,4%<\/td>\n<\/tr>\n<tr>\n<td>R&#038;D nh\u01b0 % Doanh Thu<\/td>\n<td>21,3%<\/td>\n<td>25,6%<\/td>\n<td>29,1%<\/td>\n<td>24,2%<\/td>\n<td>22,8%<\/td>\n<\/tr>\n<tr>\n<td>N\u1ee3 tr\u00ean EBITDA<\/td>\n<td>2,8<\/td>\n<td>1,9<\/td>\n<td>1,2<\/td>\n<td>3,2<\/td>\n<td>2,3<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>So s\u00e1nh n\u00e0y ti\u1ebft l\u1ed9 Pfizer cung c\u1ea5p l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c cao h\u01a1n 107% so v\u1edbi trung b\u00ecnh ng\u00e0nh (5,4% so v\u1edbi 2,6%) trong khi giao d\u1ecbch v\u1edbi m\u1ee9c chi\u1ebft kh\u1ea5u 15% so v\u1edbi t\u1ef7 l\u1ec7 P\/E trung b\u00ecnh c\u1ee7a \u0111\u1ed3ng nghi\u1ec7p (12,7 so v\u1edbi 15,0). \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 so s\u00e1nh ng\u00e0nh c\u1ee7a Pocket Option, PFE n\u1ed5i b\u1eadt v\u1edbi c\u00e1c ch\u1ec9 s\u1ed1 gi\u00e1 tr\u1ecb t\u01b0\u01a1ng \u0111\u1ed1i h\u1ea5p d\u1eabn, \u0111\u1eb7t n\u00f3 v\u00e0o nh\u00f3m tr\u00ean c\u00f9ng v\u1ec1 l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c v\u00e0 nh\u00f3m d\u01b0\u1edbi c\u00f9ng v\u1ec1 b\u1ed9i s\u1ed1 \u0111\u1ecbnh gi\u00e1 &#8211; m\u1ed9t s\u1ef1 k\u1ebft h\u1ee3p hi\u1ebfm hoi th\u01b0\u1eddng li\u00ean quan \u0111\u1ebfn c\u00e1c ch\u1ee9ng kho\u00e1n b\u1ecb \u0111\u1ecbnh gi\u00e1 th\u1ea5p.<br \/>\n    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\">B\u1eaft \u0110\u1ea7u Giao D\u1ecbch<\/span>\n        <\/a>\n    <\/div>\n    <\/p>\n<h2>K\u1ebft Lu\u1eadn: T\u1ed5ng H\u1ee3p Tr\u01b0\u1eddng H\u1ee3p \u0110\u1ea7u T\u01b0 Cho Pfizer<\/h2>\n<p>C\u00e2u h\u1ecfi &#8220;li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&#8221; cu\u1ed1i c\u00f9ng ph\u1ee5 thu\u1ed9c v\u00e0o c\u00e1c m\u1ee5c ti\u00eau \u0111\u1ea7u t\u01b0 c\u00e1 nh\u00e2n, th\u1eddi gian v\u00e0 b\u1ed1i c\u1ea3nh danh m\u1ee5c \u0111\u1ea7u t\u01b0. Tuy nhi\u00ean, m\u1ed9t s\u1ed1 quan s\u00e1t r\u00f5 r\u00e0ng n\u1ed5i l\u00ean t\u1eeb ph\u00e2n t\u00edch to\u00e0n di\u1ec7n n\u00e0y:<\/p>\n<p>Pfizer tr\u00ecnh b\u00e0y m\u1ed9t \u0111\u1ec1 xu\u1ea5t gi\u00e1 tr\u1ecb h\u1ea5p d\u1eabn v\u1edbi l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c 5,4% v\u01b0\u1ee3t qu\u00e1 93% c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu S&#038;P 500. C\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1 hi\u1ec7n t\u1ea1i c\u1ee7a n\u00f3 cho th\u1ea5y s\u1ef1 \u0111\u1ecbnh gi\u00e1 th\u1ea5p 12% d\u1ef1a tr\u00ean c\u00e1c t\u1ef7 l\u1ec7 P\/E l\u1ecbch s\u1eed 5 n\u0103m v\u00e0 chi\u1ebft kh\u1ea5u 18% so v\u1edbi b\u1ed9i s\u1ed1 ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m, cung c\u1ea5p m\u1ed9t bi\u00ean \u0111\u1ed9 an to\u00e0n ti\u1ec1m n\u0103ng. \u0110\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd c\u1ee7a c\u00f4ng ty v\u00e0 c\u00e1ch ti\u1ebfp c\u1eadn th\u00e2u t\u00f3m chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ecbnh v\u1ecb n\u00f3 cho ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng v\u01b0\u1ee3t ra ngo\u00e0i danh m\u1ee5c s\u1ea3n ph\u1ea9m tr\u01b0\u1edfng th\u00e0nh c\u1ee7a n\u00f3.<\/p>\n<p>\u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng b\u1ed9 c\u00f4ng c\u1ee5 ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m to\u00e0n di\u1ec7n c\u1ee7a Pocket Option, Pfizer \u0111\u1ea1i di\u1ec7n cho m\u1ed9t l\u1ef1a ch\u1ecdn c\u00e2n b\u1eb1ng kh\u00e1ch quan v\u1edbi c\u00e1c ch\u1ec9 s\u1ed1 c\u00f3 th\u1ec3 \u0111\u1ecbnh l\u01b0\u1ee3ng: l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c nh\u00f3m tr\u00ean c\u00f9ng (5,4%), t\u1ef7 l\u1ec7 P\/E nh\u00f3m d\u01b0\u1edbi c\u00f9ng (12,7), v\u00e0 \u0111\u1ecbnh v\u1ecb \u0111\u01b0\u1eddng \u1ed1ng chi\u1ebfn l\u01b0\u1ee3c trong c\u00e1c th\u1ecb tr\u01b0\u1eddng ung th\u01b0 d\u1ef1 ki\u1ebfn t\u0103ng tr\u01b0\u1edfng v\u1edbi CAGR 14,2% \u0111\u1ebfn n\u0103m 2030. S\u1ee9c m\u1ea1nh t\u00e0i ch\u00ednh c\u1ee7a c\u00f4ng ty h\u1ed7 tr\u1ee3 c\u1ea3 vi\u1ec7c ti\u1ebfp t\u1ee5c thanh to\u00e1n c\u1ed5 t\u1ee9c v\u00e0 s\u1ef1 linh ho\u1ea1t chi\u1ebfn l\u01b0\u1ee3c cho ph\u00e1t tri\u1ec3n trong t\u01b0\u01a1ng lai. Trong khi \u0111\u1ed1i m\u1eb7t v\u1edbi c\u00e1c th\u00e1ch th\u1ee9c to\u00e0n ng\u00e0nh bao g\u1ed3m \u00e1p l\u1ef1c gi\u00e1 v\u00e0 h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf, quy m\u00f4 v\u00e0 \u0111a d\u1ea1ng h\u00f3a c\u1ee7a Pfizer cung c\u1ea5p c\u00e1c l\u1ee3i th\u1ebf c\u1ea1nh tranh c\u00f3 \u00fd ngh\u0129a.<\/p>\n<p>Thay v\u00ec xem Pfizer ch\u1ec9 \u0111\u01a1n gi\u1ea3n l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu \u0111\u1ec3 mua ho\u1eb7c tr\u00e1nh, c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tinh vi c\u00f3 th\u1ec3 xem x\u00e9t th\u1ef1c hi\u1ec7n c\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u00e0o theo giai \u0111o\u1ea1n ho\u1eb7c c\u00e1c c\u00e1ch ti\u1ebfp c\u1eadn d\u1ef1a tr\u00ean quy\u1ec1n ch\u1ecdn \u0111\u1ec3 t\u1ed1i \u01b0u h\u00f3a s\u1ef1 ti\u1ebfp x\u00fac d\u1ef1a tr\u00ean \u0111\u1ecbnh gi\u00e1, t\u00edn hi\u1ec7u k\u1ef9 thu\u1eadt v\u00e0 ch\u1ea5t x\u00fac t\u00e1c \u0111\u01b0\u1eddng \u1ed1ng. \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm s\u1ef1 ti\u1ebfp x\u00fac v\u1edbi d\u01b0\u1ee3c ph\u1ea9m v\u1edbi c\u00e1c \u0111\u1eb7c \u0111i\u1ec3m thu nh\u1eadp, PFE \u0111\u00e1ng \u0111\u01b0\u1ee3c xem x\u00e9t cho m\u1ed9t ph\u00e2n b\u1ed5 danh m\u1ee5c \u0111\u1ea7u t\u01b0 3-5% nh\u01b0 m\u1ed9t ph\u1ea7n c\u1ed1t l\u00f5i c\u1ee7a danh m\u1ee5c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe, v\u1edbi c\u00e1c l\u1ea7n v\u00e0o theo giai \u0111o\u1ea1n t\u1ea1i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 k\u1ef9 thu\u1eadt c\u00f3 th\u1ec3 th\u1ea5y tr\u00ean c\u00e1c c\u00f4ng c\u1ee5 ph\u00e2n t\u00edch \u0111a khung th\u1eddi gian c\u1ee7a Pocket Option.<\/p>\n<\/div>\n"},"faq":[{"question":"C\u00e1c y\u1ebfu t\u1ed1 ch\u00ednh c\u1ea7n xem x\u00e9t khi quy\u1ebft \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua hay kh\u00f4ng?","answer":"Khi \u0111\u00e1nh gi\u00e1 Pfizer nh\u01b0 m\u1ed9t kho\u1ea3n \u0111\u1ea7u t\u01b0, h\u00e3y xem x\u00e9t l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a n\u00f3 (hi\u1ec7n t\u1ea1i l\u00e0 5,4% - thu\u1ed9c top 3% trong s\u1ed1 c\u00e1c c\u00f4ng ty S&P 500), t\u1ef7 l\u1ec7 P\/E (12,7, \u0111\u1ea1i di\u1ec7n cho m\u1ee9c chi\u1ebft kh\u1ea5u 15% so v\u1edbi c\u00e1c \u0111\u1ed1i th\u1ee7 d\u01b0\u1ee3c ph\u1ea9m), ti\u1ec1m n\u0103ng \u0111\u01b0\u1eddng \u1ed1ng (26 \u1ee9ng vi\u00ean giai \u0111o\u1ea1n cu\u1ed1i v\u1edbi doanh thu h\u00e0ng n\u0103m d\u1ef1 ki\u1ebfn 9,7 t\u1ef7 USD), c\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c (Seagen \u0111\u00e3 \u0111\u00f3ng g\u00f3p 650 tri\u1ec7u USD h\u00e0ng qu\u00fd), v\u00e0 v\u1ecb th\u1ebf c\u1ea1nh tranh trong ng\u00e0nh. D\u00f2ng ti\u1ec1n t\u1ef1 do h\u00e0ng n\u0103m 18,3 t\u1ef7 USD c\u1ee7a c\u00f4ng ty cung c\u1ea5p s\u1ef1 linh ho\u1ea1t t\u00e0i ch\u00ednh \u0111\u00e1ng k\u1ec3 trong khi duy tr\u00ec 14 n\u0103m li\u00ean ti\u1ebfp t\u0103ng tr\u01b0\u1edfng c\u1ed5 t\u1ee9c b\u1ea5t ch\u1ea5p nh\u1eefng kh\u00f3 kh\u0103n trong ng\u00e0nh."},{"question":"C\u1ed5 t\u1ee9c c\u1ee7a Pfizer so v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m kh\u00e1c nh\u01b0 th\u1ebf n\u00e0o?","answer":"Pfizer cung c\u1ea5p m\u1ed9t trong nh\u1eefng h\u1ed3 s\u01a1 c\u1ed5 t\u1ee9c h\u1ea5p d\u1eabn nh\u1ea5t trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m v\u1edbi l\u1ee3i su\u1ea5t 5,4% so v\u1edbi m\u1ee9c trung b\u00ecnh c\u1ee7a ng\u00e0nh l\u00e0 2,6% - \u0111\u1ea1i di\u1ec7n cho m\u1ee9c cao h\u01a1n 107%. C\u00f4ng ty \u0111\u00e3 duy tr\u00ec 14 n\u0103m li\u00ean ti\u1ebfp t\u0103ng c\u1ed5 t\u1ee9c (so v\u1edbi m\u1ee9c trung b\u00ecnh c\u1ee7a ng\u00e0nh l\u00e0 8,3 n\u0103m) v\u1edbi t\u1ef7 l\u1ec7 t\u0103ng tr\u01b0\u1edfng h\u00e0ng n\u0103m l\u00e0 3,7%. \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 thu nh\u1eadp, kho\u1ea3n \u0111\u1ea7u t\u01b0 $10,000 v\u00e0o PFE t\u1ea1o ra kho\u1ea3ng $540 h\u00e0ng n\u0103m so v\u1edbi ch\u1ec9 $280 t\u1eeb c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m trung b\u00ecnh. S\u1ef1 nh\u1ea5t qu\u00e1n trong c\u1ed5 t\u1ee9c n\u00e0y \u0111\u00e3 thi\u1ebft l\u1eadp h\u1ed7 tr\u1ee3 gi\u00e1 l\u1ecbch s\u1eed \u1edf m\u1ee9c kho\u1ea3ng $30 d\u1ef1a tr\u00ean c\u00e1c m\u00f4 h\u00ecnh tr\u1ea7n l\u1ee3i su\u1ea5t."},{"question":"Nh\u1eefng t\u00e1c \u0111\u1ed9ng n\u00e0o m\u00e0 c\u00e1c v\u1ee5 mua l\u1ea1i g\u1ea7n \u0111\u00e2y c\u1ee7a Pfizer c\u00f3 th\u1ec3 c\u00f3 \u0111\u1ed1i v\u1edbi hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu trong t\u01b0\u01a1ng lai?","answer":"C\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Pfizer, \u0111\u1eb7c bi\u1ec7t l\u00e0 vi\u1ec7c mua Seagen tr\u1ecb gi\u00e1 43 t\u1ef7 USD, \u0111\u00e3 t\u0103ng c\u01b0\u1eddng \u0111\u00e1ng k\u1ec3 danh m\u1ee5c ung th\u01b0 c\u1ee7a c\u00f4ng ty v\u1edbi c\u00f4ng ngh\u1ec7 li\u00ean h\u1ee3p kh\u00e1ng th\u1ec3-thu\u1ed1c, hi\u1ec7n \u0111ang \u0111\u00f3ng g\u00f3p 650 tri\u1ec7u USD h\u00e0ng qu\u00fd (cao h\u01a1n 12% so v\u1edbi d\u1ef1 \u0111o\u00e1n c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch). Ph\u00e2n t\u00edch l\u1ecbch s\u1eed v\u1ec1 vi\u1ec7c t\u00edch h\u1ee3p mua l\u1ea1i c\u1ee7a Pfizer cho th\u1ea5y l\u1ee3i t\u1ee9c \u0111\u1ea7u t\u01b0 h\u00e0ng n\u0103m trung b\u00ecnh l\u00e0 13,7% trong c\u00e1c giai \u0111o\u1ea1n n\u0103m n\u0103m. Vi\u1ec7c mua l\u1ea1i Arena Pharmaceuticals (6,7 t\u1ef7 USD) \u0111\u00e3 mang l\u1ea1i s\u1ef1 ch\u1ea5p thu\u1eadn c\u1ee7a FDA cho etrasimod v\u1edbi doanh s\u1ed1 \u0111\u1ec9nh d\u1ef1 ki\u1ebfn l\u00e0 3,1 t\u1ef7 USD, trong khi TTI-622 c\u1ee7a Trillium Therapeutics cho th\u1ea5y t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng 37% trong c\u00e1c lo\u1ea1i ung th\u01b0 m\u00e1u kh\u00f3 \u0111i\u1ec1u tr\u1ecb. Nh\u1eefng th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i n\u00e0y c\u00f9ng nhau \u0111\u1ecbnh v\u1ecb Pfizer c\u00f3 kh\u1ea3 n\u0103ng chi\u1ebfm 15-20% th\u1ecb tr\u01b0\u1eddng ung th\u01b0 tr\u1ecb gi\u00e1 280 t\u1ef7 USD \u0111ang ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng v\u00e0o n\u0103m 2028."},{"question":"Vi\u1ec7c h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng nh\u01b0 th\u1ebf n\u00e0o \u0111\u1ebfn doanh thu v\u00e0 gi\u00e1 c\u1ed5 phi\u1ebfu t\u01b0\u01a1ng lai c\u1ee7a Pfizer?","answer":"H\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf l\u00e0 th\u00e1ch th\u1ee9c l\u1edbn nh\u1ea5t trong ng\u1eafn h\u1ea1n c\u1ee7a Pfizer, v\u1edbi Eliquis (2026) \u0111\u1eb7t 4,8 t\u1ef7 USD doanh thu h\u00e0ng n\u0103m v\u00e0o t\u00ecnh tr\u1ea1ng r\u1ee7i ro. Trong l\u1ecbch s\u1eed, Pfizer \u0111\u00e3 tr\u1ea3i qua s\u1ef1 gi\u1ea3m gi\u00e1 c\u1ed5 phi\u1ebfu t\u1eeb 8-12% sau khi h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf l\u1edbn v\u00ec c\u00e1c s\u1ea3n ph\u1ea9m c\u00f3 th\u01b0\u01a1ng hi\u1ec7u th\u01b0\u1eddng m\u1ea5t 80-90% doanh thu trong v\u00f2ng 24 th\u00e1ng sau khi c\u00f3 s\u1ef1 xu\u1ea5t hi\u1ec7n c\u1ee7a s\u1ea3n ph\u1ea9m generic. Tuy nhi\u00ean, danh m\u1ee5c \u0111a d\u1ea1ng c\u1ee7a c\u00f4ng ty, c\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 26 \u1ee9ng vi\u00ean trong giai \u0111o\u1ea1n cu\u1ed1i c\u1ee7a \u0111\u01b0\u1eddng \u1ed1ng cung c\u1ea5p ti\u1ec1m n\u0103ng b\u00f9 \u0111\u1eafp \u0111\u00e1ng k\u1ec3. Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng Pocket Option cho th\u1ea5y c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u01b0\u1eddng gi\u1ea3m gi\u00e1 t\u00e1c \u0111\u1ed9ng c\u1ee7a v\u00e1ch \u0111\u00e1 b\u1eb1ng s\u00e1ng ch\u1ebf t\u1eeb 18-24 th\u00e1ng tr\u01b0\u1edbc khi h\u1ebft h\u1ea1n, cho th\u1ea5y gi\u00e1 PFE hi\u1ec7n t\u1ea1i \u0111\u00e3 ph\u1ea3n \u00e1nh m\u1ed9t ph\u1ea7n y\u1ebfu t\u1ed1 r\u1ee7i ro n\u00e0y."},{"question":"Nh\u1eefng chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch n\u00e0o m\u00e0 c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng v\u1edbi c\u1ed5 phi\u1ebfu Pfizer tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng nh\u01b0 Pocket Option?","answer":"C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng Pocket Option \u00e1p d\u1ee5ng b\u1ed1n chi\u1ebfn l\u01b0\u1ee3c ch\u00ednh v\u1edbi c\u1ed5 phi\u1ebfu Pfizer, m\u1ed7i chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ec1u c\u00f3 c\u00e1c ch\u1ec9 s\u1ed1 hi\u1ec7u su\u1ea5t \u0111\u01b0\u1ee3c ghi nh\u1eadn: 1) T\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c t\u1eadp trung v\u00e0o thu nh\u1eadp (l\u1ee3i nhu\u1eadn h\u00e0ng n\u0103m 9,2% t\u1eeb 2018-2024) nh\u1eafm v\u00e0o l\u1ee3i su\u1ea5t 5,4% c\u1ee7a c\u1ed5 phi\u1ebfu; 2) T\u00edch l\u0169y d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 s\u00e0ng l\u1ecdc l\u1ee3i su\u1ea5t \u0111a khung th\u1eddi gian c\u1ee7a Pocket Option khi P\/E gi\u1ea3m xu\u1ed1ng d\u01b0\u1edbi 13 v\u00e0 l\u1ee3i su\u1ea5t v\u01b0\u1ee3t qu\u00e1 4,5% (l\u1ee3i nhu\u1eadn h\u00e0ng n\u0103m 12,7%); 3) Giao d\u1ecbch theo s\u1ef1 ki\u1ec7n v\u1edbi c\u00e1c chi\u1ebfn l\u01b0\u1ee3c quy\u1ec1n ch\u1ecdn xung quanh c\u00e1c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u00e0 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng (18,3% m\u1ed7i giao d\u1ecbch v\u1edbi t\u1ef7 l\u1ec7 th\u1eafng 63%); v\u00e0 4) Ph\u01b0\u01a1ng ph\u00e1p ph\u00e2n b\u1ed5 theo ng\u00e0nh s\u1eed d\u1ee5ng PFE nh\u01b0 m\u1ed9t kho\u1ea3n \u0111\u1ea7u t\u01b0 ph\u00f2ng th\u1ee7 trong l\u0129nh v\u1ef1c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe (l\u1ee3i nhu\u1eadn h\u00e0ng n\u0103m 7,8%). C\u00e1c nh\u00e0 giao d\u1ecbch k\u1ef9 thu\u1eadt \u0111\u1eb7c bi\u1ec7t theo d\u00f5i ba m\u00f4 h\u00ecnh c\u00f3 x\u00e1c su\u1ea5t cao: \u0111\u00e1y k\u00e9p (t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng 75%), giao c\u1eaft v\u00e0ng (t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng 83%), v\u00e0 ph\u00e2n k\u1ef3 RSI d\u01b0\u01a1ng (t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng 67%)."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"C\u00e1c y\u1ebfu t\u1ed1 ch\u00ednh c\u1ea7n xem x\u00e9t khi quy\u1ebft \u0111\u1ecbnh li\u1ec7u PFE c\u00f3 ph\u1ea3i l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua hay kh\u00f4ng?","answer":"Khi \u0111\u00e1nh gi\u00e1 Pfizer nh\u01b0 m\u1ed9t kho\u1ea3n \u0111\u1ea7u t\u01b0, h\u00e3y xem x\u00e9t l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a n\u00f3 (hi\u1ec7n t\u1ea1i l\u00e0 5,4% - thu\u1ed9c top 3% trong s\u1ed1 c\u00e1c c\u00f4ng ty S&P 500), t\u1ef7 l\u1ec7 P\/E (12,7, \u0111\u1ea1i di\u1ec7n cho m\u1ee9c chi\u1ebft kh\u1ea5u 15% so v\u1edbi c\u00e1c \u0111\u1ed1i th\u1ee7 d\u01b0\u1ee3c ph\u1ea9m), ti\u1ec1m n\u0103ng \u0111\u01b0\u1eddng \u1ed1ng (26 \u1ee9ng vi\u00ean giai \u0111o\u1ea1n cu\u1ed1i v\u1edbi doanh thu h\u00e0ng n\u0103m d\u1ef1 ki\u1ebfn 9,7 t\u1ef7 USD), c\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c (Seagen \u0111\u00e3 \u0111\u00f3ng g\u00f3p 650 tri\u1ec7u USD h\u00e0ng qu\u00fd), v\u00e0 v\u1ecb th\u1ebf c\u1ea1nh tranh trong ng\u00e0nh. D\u00f2ng ti\u1ec1n t\u1ef1 do h\u00e0ng n\u0103m 18,3 t\u1ef7 USD c\u1ee7a c\u00f4ng ty cung c\u1ea5p s\u1ef1 linh ho\u1ea1t t\u00e0i ch\u00ednh \u0111\u00e1ng k\u1ec3 trong khi duy tr\u00ec 14 n\u0103m li\u00ean ti\u1ebfp t\u0103ng tr\u01b0\u1edfng c\u1ed5 t\u1ee9c b\u1ea5t ch\u1ea5p nh\u1eefng kh\u00f3 kh\u0103n trong ng\u00e0nh."},{"question":"C\u1ed5 t\u1ee9c c\u1ee7a Pfizer so v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m kh\u00e1c nh\u01b0 th\u1ebf n\u00e0o?","answer":"Pfizer cung c\u1ea5p m\u1ed9t trong nh\u1eefng h\u1ed3 s\u01a1 c\u1ed5 t\u1ee9c h\u1ea5p d\u1eabn nh\u1ea5t trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m v\u1edbi l\u1ee3i su\u1ea5t 5,4% so v\u1edbi m\u1ee9c trung b\u00ecnh c\u1ee7a ng\u00e0nh l\u00e0 2,6% - \u0111\u1ea1i di\u1ec7n cho m\u1ee9c cao h\u01a1n 107%. C\u00f4ng ty \u0111\u00e3 duy tr\u00ec 14 n\u0103m li\u00ean ti\u1ebfp t\u0103ng c\u1ed5 t\u1ee9c (so v\u1edbi m\u1ee9c trung b\u00ecnh c\u1ee7a ng\u00e0nh l\u00e0 8,3 n\u0103m) v\u1edbi t\u1ef7 l\u1ec7 t\u0103ng tr\u01b0\u1edfng h\u00e0ng n\u0103m l\u00e0 3,7%. \u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 thu nh\u1eadp, kho\u1ea3n \u0111\u1ea7u t\u01b0 $10,000 v\u00e0o PFE t\u1ea1o ra kho\u1ea3ng $540 h\u00e0ng n\u0103m so v\u1edbi ch\u1ec9 $280 t\u1eeb c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m trung b\u00ecnh. S\u1ef1 nh\u1ea5t qu\u00e1n trong c\u1ed5 t\u1ee9c n\u00e0y \u0111\u00e3 thi\u1ebft l\u1eadp h\u1ed7 tr\u1ee3 gi\u00e1 l\u1ecbch s\u1eed \u1edf m\u1ee9c kho\u1ea3ng $30 d\u1ef1a tr\u00ean c\u00e1c m\u00f4 h\u00ecnh tr\u1ea7n l\u1ee3i su\u1ea5t."},{"question":"Nh\u1eefng t\u00e1c \u0111\u1ed9ng n\u00e0o m\u00e0 c\u00e1c v\u1ee5 mua l\u1ea1i g\u1ea7n \u0111\u00e2y c\u1ee7a Pfizer c\u00f3 th\u1ec3 c\u00f3 \u0111\u1ed1i v\u1edbi hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu trong t\u01b0\u01a1ng lai?","answer":"C\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Pfizer, \u0111\u1eb7c bi\u1ec7t l\u00e0 vi\u1ec7c mua Seagen tr\u1ecb gi\u00e1 43 t\u1ef7 USD, \u0111\u00e3 t\u0103ng c\u01b0\u1eddng \u0111\u00e1ng k\u1ec3 danh m\u1ee5c ung th\u01b0 c\u1ee7a c\u00f4ng ty v\u1edbi c\u00f4ng ngh\u1ec7 li\u00ean h\u1ee3p kh\u00e1ng th\u1ec3-thu\u1ed1c, hi\u1ec7n \u0111ang \u0111\u00f3ng g\u00f3p 650 tri\u1ec7u USD h\u00e0ng qu\u00fd (cao h\u01a1n 12% so v\u1edbi d\u1ef1 \u0111o\u00e1n c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch). Ph\u00e2n t\u00edch l\u1ecbch s\u1eed v\u1ec1 vi\u1ec7c t\u00edch h\u1ee3p mua l\u1ea1i c\u1ee7a Pfizer cho th\u1ea5y l\u1ee3i t\u1ee9c \u0111\u1ea7u t\u01b0 h\u00e0ng n\u0103m trung b\u00ecnh l\u00e0 13,7% trong c\u00e1c giai \u0111o\u1ea1n n\u0103m n\u0103m. Vi\u1ec7c mua l\u1ea1i Arena Pharmaceuticals (6,7 t\u1ef7 USD) \u0111\u00e3 mang l\u1ea1i s\u1ef1 ch\u1ea5p thu\u1eadn c\u1ee7a FDA cho etrasimod v\u1edbi doanh s\u1ed1 \u0111\u1ec9nh d\u1ef1 ki\u1ebfn l\u00e0 3,1 t\u1ef7 USD, trong khi TTI-622 c\u1ee7a Trillium Therapeutics cho th\u1ea5y t\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng 37% trong c\u00e1c lo\u1ea1i ung th\u01b0 m\u00e1u kh\u00f3 \u0111i\u1ec1u tr\u1ecb. Nh\u1eefng th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i n\u00e0y c\u00f9ng nhau \u0111\u1ecbnh v\u1ecb Pfizer c\u00f3 kh\u1ea3 n\u0103ng chi\u1ebfm 15-20% th\u1ecb tr\u01b0\u1eddng ung th\u01b0 tr\u1ecb gi\u00e1 280 t\u1ef7 USD \u0111ang ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng v\u00e0o n\u0103m 2028."},{"question":"Vi\u1ec7c h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng nh\u01b0 th\u1ebf n\u00e0o \u0111\u1ebfn doanh thu v\u00e0 gi\u00e1 c\u1ed5 phi\u1ebfu t\u01b0\u01a1ng lai c\u1ee7a Pfizer?","answer":"H\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf l\u00e0 th\u00e1ch th\u1ee9c l\u1edbn nh\u1ea5t trong ng\u1eafn h\u1ea1n c\u1ee7a Pfizer, v\u1edbi Eliquis (2026) \u0111\u1eb7t 4,8 t\u1ef7 USD doanh thu h\u00e0ng n\u0103m v\u00e0o t\u00ecnh tr\u1ea1ng r\u1ee7i ro. Trong l\u1ecbch s\u1eed, Pfizer \u0111\u00e3 tr\u1ea3i qua s\u1ef1 gi\u1ea3m gi\u00e1 c\u1ed5 phi\u1ebfu t\u1eeb 8-12% sau khi h\u1ebft h\u1ea1n b\u1eb1ng s\u00e1ng ch\u1ebf l\u1edbn v\u00ec c\u00e1c s\u1ea3n ph\u1ea9m c\u00f3 th\u01b0\u01a1ng hi\u1ec7u th\u01b0\u1eddng m\u1ea5t 80-90% doanh thu trong v\u00f2ng 24 th\u00e1ng sau khi c\u00f3 s\u1ef1 xu\u1ea5t hi\u1ec7n c\u1ee7a s\u1ea3n ph\u1ea9m generic. Tuy nhi\u00ean, danh m\u1ee5c \u0111a d\u1ea1ng c\u1ee7a c\u00f4ng ty, c\u00e1c th\u01b0\u01a1ng v\u1ee5 mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 26 \u1ee9ng vi\u00ean trong giai \u0111o\u1ea1n cu\u1ed1i c\u1ee7a \u0111\u01b0\u1eddng \u1ed1ng cung c\u1ea5p ti\u1ec1m n\u0103ng b\u00f9 \u0111\u1eafp \u0111\u00e1ng k\u1ec3. Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng Pocket Option cho th\u1ea5y c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u01b0\u1eddng gi\u1ea3m gi\u00e1 t\u00e1c \u0111\u1ed9ng c\u1ee7a v\u00e1ch \u0111\u00e1 b\u1eb1ng s\u00e1ng ch\u1ebf t\u1eeb 18-24 th\u00e1ng tr\u01b0\u1edbc khi h\u1ebft h\u1ea1n, cho th\u1ea5y gi\u00e1 PFE hi\u1ec7n t\u1ea1i \u0111\u00e3 ph\u1ea3n \u00e1nh m\u1ed9t ph\u1ea7n y\u1ebfu t\u1ed1 r\u1ee7i ro n\u00e0y."},{"question":"Nh\u1eefng chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch n\u00e0o m\u00e0 c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng v\u1edbi c\u1ed5 phi\u1ebfu Pfizer tr\u00ean c\u00e1c n\u1ec1n t\u1ea3ng nh\u01b0 Pocket Option?","answer":"C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 s\u1eed d\u1ee5ng Pocket Option \u00e1p d\u1ee5ng b\u1ed1n chi\u1ebfn l\u01b0\u1ee3c ch\u00ednh v\u1edbi c\u1ed5 phi\u1ebfu Pfizer, m\u1ed7i chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ec1u c\u00f3 c\u00e1c ch\u1ec9 s\u1ed1 hi\u1ec7u su\u1ea5t \u0111\u01b0\u1ee3c ghi nh\u1eadn: 1) T\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c t\u1eadp trung v\u00e0o thu nh\u1eadp (l\u1ee3i nhu\u1eadn h\u00e0ng n\u0103m 9,2% t\u1eeb 2018-2024) nh\u1eafm v\u00e0o l\u1ee3i su\u1ea5t 5,4% c\u1ee7a c\u1ed5 phi\u1ebfu; 2) T\u00edch l\u0169y d\u1ef1a tr\u00ean gi\u00e1 tr\u1ecb s\u1eed d\u1ee5ng c\u00f4ng c\u1ee5 s\u00e0ng l\u1ecdc l\u1ee3i su\u1ea5t \u0111a khung th\u1eddi gian c\u1ee7a Pocket Option khi P\/E gi\u1ea3m xu\u1ed1ng d\u01b0\u1edbi 13 v\u00e0 l\u1ee3i su\u1ea5t v\u01b0\u1ee3t qu\u00e1 4,5% (l\u1ee3i nhu\u1eadn h\u00e0ng n\u0103m 12,7%); 3) Giao d\u1ecbch theo s\u1ef1 ki\u1ec7n v\u1edbi c\u00e1c chi\u1ebfn l\u01b0\u1ee3c quy\u1ec1n ch\u1ecdn xung quanh c\u00e1c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u00e0 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng (18,3% m\u1ed7i giao d\u1ecbch v\u1edbi t\u1ef7 l\u1ec7 th\u1eafng 63%); v\u00e0 4) Ph\u01b0\u01a1ng ph\u00e1p ph\u00e2n b\u1ed5 theo ng\u00e0nh s\u1eed d\u1ee5ng PFE nh\u01b0 m\u1ed9t kho\u1ea3n \u0111\u1ea7u t\u01b0 ph\u00f2ng th\u1ee7 trong l\u0129nh v\u1ef1c ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe (l\u1ee3i nhu\u1eadn h\u00e0ng n\u0103m 7,8%). C\u00e1c nh\u00e0 giao d\u1ecbch k\u1ef9 thu\u1eadt \u0111\u1eb7c bi\u1ec7t theo d\u00f5i ba m\u00f4 h\u00ecnh c\u00f3 x\u00e1c su\u1ea5t cao: \u0111\u00e1y k\u00e9p (t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng 75%), giao c\u1eaft v\u00e0ng (t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng 83%), v\u00e0 ph\u00e2n k\u1ef3 RSI d\u01b0\u01a1ng (t\u1ef7 l\u1ec7 th\u00e0nh c\u00f4ng 67%)."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>&quot;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&quot;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"&quot;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&quot;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-19T11:47:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Tatiana OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatiana OK\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\"},\"author\":{\"name\":\"Tatiana OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"headline\":\"&#8220;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&#8221;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer\",\"datePublished\":\"2025-07-19T11:47:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\"},\"wordCount\":26,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp\",\"keywords\":[\"investment\",\"platform\",\"stock\",\"strategy\"],\"articleSection\":[\"Trading\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\",\"name\":\"\\\"PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua\\\": Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp\",\"datePublished\":\"2025-07-19T11:47:06+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"&#8220;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&#8221;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\",\"name\":\"Tatiana OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"caption\":\"Tatiana OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/tatiana\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\"PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua\": Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/","og_locale":"en_US","og_type":"article","og_title":"\"PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua\": Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer","og_url":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/","og_site_name":"Pocket Option blog","article_published_time":"2025-07-19T11:47:06+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp","type":"image\/webp"}],"author":"Tatiana OK","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatiana OK"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/"},"author":{"name":"Tatiana OK","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"headline":"&#8220;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&#8221;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer","datePublished":"2025-07-19T11:47:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/"},"wordCount":26,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp","keywords":["investment","platform","stock","strategy"],"articleSection":["Trading"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/","url":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/","name":"\"PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua\": Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp","datePublished":"2025-07-19T11:47:06+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026625968-290974773-1.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"&#8220;PFE c\u00f3 ph\u1ea3i l\u00e0 c\u1ed5 phi\u1ebfu t\u1ed1t \u0111\u1ec3 mua&#8221;: Kh\u00e1m ph\u00e1 ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 \u1ea9n gi\u1ea5u c\u1ee7a Pfizer"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d","name":"Tatiana OK","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","caption":"Tatiana OK"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/tatiana\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":315902,"slug":"is-pfe-a-good-stock-to-buy","post_title":"\"PFE \u00e9 uma Boa A\u00e7\u00e3o para Comprar\": Revelando o Potencial de Investimento Oculto da Pfizer","href":"https:\/\/pocketoption.com\/blog\/pt\/knowledge-base\/trading\/is-pfe-a-good-stock-to-buy\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/315907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=315907"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/315907\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/184208"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=315907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=315907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=315907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}